Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Epidemiology
Published in: European Journal of Epidemiology 5/2020

Open Access 01-05-2020 | STUDY UPDATE

Objectives, design and main findings until 2020 from the Rotterdam Study

Authors: M. Arfan Ikram, Guy Brusselle, Mohsen Ghanbari, André Goedegebure, M. Kamran Ikram, Maryam Kavousi, Brenda C. T. Kieboom, Caroline C. W. Klaver, Robert J. de Knegt, Annemarie I. Luik, Tamar E. C. Nijsten, Robin P. Peeters, Frank J. A. van Rooij, Bruno H. Stricker, André G. Uitterlinden, Meike W. Vernooij, Trudy Voortman

Published in: European Journal of Epidemiology | Issue 5/2020

Login to get access

Abstract

The Rotterdam Study is an ongoing prospective cohort study that started in 1990 in the city of Rotterdam, The Netherlands. The study aims to unravel etiology, preclinical course, natural history and potential targets for intervention for chronic diseases in mid-life and late-life. The study focuses on cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. Since 2016, the cohort is being expanded by persons aged 40 years and over. The findings of the Rotterdam Study have been presented in over 1700 research articles and reports. This article provides an update on the rationale and design of the study. It also presents a summary of the major findings from the preceding 3 years and outlines developments for the coming period.
Literature
1.
Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029–31.PubMedCrossRef
2.
3.
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403–22.PubMedCrossRef
4.
Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819–29.PubMedPubMedCentralCrossRef
5.
Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011;26(8):657–86.PubMedPubMedCentralCrossRef
6.
Biele G, Gustavson K, Czajkowski NO, Nilsen RM, Reichborn-Kjennerud T, Magnus PM, et al. Bias from self selection and loss to follow-up in prospective cohort studies. Eur J Epidemiol. 2019;34(10):927–38.PubMedCrossRef
7.
Busija L, Lim K, Szoeke C, Sanders KM, McCabe MP. Do replicable profiles of multimorbidity exist? Systematic review and synthesis. Eur J Epidemiol. 2019;34(11):1025–53.PubMedCrossRef
8.
Huitfeldt A, Swanson SA, Stensrud MJ, Suzuki E. Effect heterogeneity and variable selection for standardizing causal effects to a target population. Eur J Epidemiol. 2019;34(12):1119–29.PubMedCrossRef
9.
Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, et al. Rationale and design of the Hamburg City Health Study. Eur J Epidemiol. 2020;35(2)169–81. PubMedCrossRef
10.
Latten BGH, Overbeek LIH, Kubat B, Hausen AZ, Schouten LJ. A quarter century of decline of autopsies in the Netherlands. Eur J Epidemiol. 2019;34(12):1171–4.PubMedCrossRef
11.
Muka T, Glisic M, Milic J, Verhoog S, Bohlius J, Bramer W, et al. A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research. Eur J Epidemiol. 2020;35(1):49–60.PubMedCrossRef
12.
Nilsson A, Bonander C, Stromberg U, Bjork J. Assessing heterogeneous effects and their determinants via estimation of potential outcomes. Eur J Epidemiol. 2019;34(9):823–35.PubMedPubMedCentralCrossRef
13.
Dahabreh IJ, Hernan MA. Extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2019;34(8):719–22.PubMedCrossRef
14.
Doncarli A, Demiguel V, Canu IG, Goulet V, Bayart S, Calvez T, et al. FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders. Eur J Epidemiol. 2019;34(5):521–32.PubMedCrossRef
15.
Papatheodorou S. Umbrella reviews: what they are and why we need them. Eur J Epidemiol. 2019;34(6):543–6.PubMedCrossRef
16.
Stephan AJ, Strobl R, Schwettmann L, Meisinger C, Ladwig KH, Linkohr B, et al. Being born in the aftermath of World War II increases the risk for health deficit accumulation in older age: results from the KORA-Age study. Eur J Epidemiol. 2019;34(7):675–87.PubMedCrossRef
17.
Waziry R, Gras L, Sedaghat S, Tiemeier H, Weverling GJ, Ghanbari M, et al. Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach. Eur J Epidemiol. 2019;34(8):793–9.PubMedCrossRef
18.
Weiss NS. Generalizing from the results of randomized studies of treatment: can non-randomized studies be of help? Eur J Epidemiol. 2019;34(8):715–8.PubMedCrossRef
19.
Hoffmann W, Latza U, Baumeister SE, Brunger M, Buttmann-Schweiger N, Hardt J, et al. Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP): a guideline developed by the German Society for Epidemiology. Eur J Epidemiol. 2019;34(3):301–17.PubMedPubMedCentralCrossRef
20.
Holstege H, Beker N, Dijkstra T, Pieterse K, Wemmenhove E, Schouten K, et al. The 100-plus study of cognitively healthy centenarians: rationale, design and cohort description. Eur J Epidemiol. 2018;33(12):1229–49.PubMedPubMedCentralCrossRef
21.
Ludvigsson JF, Svedberg P, Olen O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–37.PubMedPubMedCentralCrossRef
22.
Middeldorp CM, Mahajan A, Horikoshi M, Robertson NR, Beaumont RN, Bradfield JP, et al. The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects. Eur J Epidemiol. 2019;34(3):279–300.PubMedPubMedCentralCrossRef
23.
Padmanabhan S, Carty L, Cameron E, Ghosh RE, Williams R, Strongman H. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. 2019;34(1):91–9.PubMedCrossRef
24.
Sillesen AS, Raja AA, Pihl C, Vogg ROB, Hedegaard M, Emmersen P, et al. Copenhagen Baby Heart Study: a population study of newborns with prenatal inclusion. Eur J Epidemiol. 2019;34(1):79–90.PubMedCrossRef
25.
Sterner TR, Ahlner F, Blennow K, Dahlin-Ivanoff S, Falk H, Johansson LH, et al. The Gothenburg H70 Birth cohort study 2014–16: design, methods and study population. Eur J Epidemiol. 2019;34(2):191–209.CrossRef
26.
Wiebe T, Hjorth L, Kelly MM, Linge HM, Garwicz S. A population based pediatric oncology registry in Southern Sweden: the BORISS registry. Eur J Epidemiol. 2018;33(11):1125–9.PubMedPubMedCentralCrossRef
27.
Bliddal M, Broe A, Pottegard A, Olsen J, Langhoff-Roos J. The Danish medical birth register. Eur J Epidemiol. 2018;33(1):27–36.PubMedCrossRef
28.
Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol. 2018;33(3):335–49.PubMedPubMedCentralCrossRef
29.
McDonald L, Schultze A, Carroll R, Ramagopalan SV. Performing studies using the UK Clinical Practice Research Datalink: to link or not to link? Eur J Epidemiol. 2018;33(6):601–5.PubMedCrossRef
30.
Fest J, Ruiter R, van Rooij FJ, van der Geest LG, Lemmens VE, Ikram MA, et al. Underestimation of pancreatic cancer in the national cancer registry—reconsidering the incidence and survival rates. Eur J Cancer. 2017;72:186–91.PubMedCrossRef
31.
Fest J, Vijfhuizen LS, Goeman JJ, Veth O, Joensuu A, Perola M, et al. Search for early pancreatic cancer blood biomarkers in five european prospective population biobanks using metabolomics. Endocrinology. 2019;160(7):1731–42.PubMedPubMedCentralCrossRef
32.
Licher S, Heshmatollah A, van der Willik KD, Stricker BHC, Ruiter R, de Roos EW, et al. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: a population-based cohort study. PLoS Med. 2019;16(2):e1002741.PubMedPubMedCentralCrossRef
33.
Marcondes LH, Franco OH, Ruiter R, Ikram MA, Mulder M, Stricker BH, et al. Animal foods and postmenopausal breast cancer risk: a prospective cohort study. Br J Nutr. 2019;5:1–9.
34.
Viana Veloso GG, Franco OH, Ruiter R, de Keyser CE, Hofman A, Stricker BC, et al. Baseline dietary glutamic acid intake and the risk of colorectal cancer: the Rotterdam study. Cancer. 2016;122(6):899–907.PubMedCrossRef
35.
Muka T, Kraja B, Ruiter R, de Keyser CE, Hofman A, Stricker BH, et al. Dietary polyunsaturated fatty acids intake modifies the positive association between serum total cholesterol and colorectal cancer risk: the Rotterdam Study. J Epidemiol Comm Health. 2016;70(9):881–7.CrossRef
36.
Muka T, Kraja B, Ruiter R, Lahousse L, de Keyser CE, Hofman A, et al. Dietary mineral intake and lung cancer risk: the Rotterdam Study. Eur J Nutr. 2017;56(4):1637–46.PubMedCrossRef
37.
Ordonez-Mena JM, Walter V, Schottker B, Jenab M, O'Doherty MG, Kee F, et al. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium. Ann Oncol. 2018;29(2):472–83.PubMedCrossRef
38.
Ordonez-Mena JM, Schottker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, et al. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med. 2016;14:62.PubMedPubMedCentralCrossRef
39.
Fest J, Ruiter R, Mooijaart SP, Ikram MA, van Eijck CHJ, Stricker BH. Erythrocyte sedimentation rate as an independent prognostic marker for mortality: a prospective population-based cohort study. J Intern Med. 2019;285(3):341–8.PubMed
40.
Fest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer. 2019;146:692–8.PubMedPubMedCentralCrossRef
41.
Fest J, Ruiter TR, Groot Koerkamp B, Rizopoulos D, Ikram MA, van Eijck CHJ, et al. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam Study. Eur J Epidemiol. 2019;34(5):463–70.PubMedCrossRef
42.
43.
van der Willik KD, Ruiter R, Wolters FJ, Ikram MK, Stricker BH, Hauptmann M, et al. Mild cognitive impairment and dementia show contrasting associations with risk of cancer. Neuroepidemiology. 2018;50(3–4):207–15.PubMed
44.
Voortman T, Kiefte-de Jong JC, Ikram MA, Stricker BH, van Rooij FJA, Lahousse L, et al. Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam Study. Eur J Epidemiol. 2017;32(11):993–1005.PubMedPubMedCentralCrossRef
45.
Khan SR, Chaker L, Ruiter R, Aerts JG, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(12):5030–6.PubMedCrossRef
46.
Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566.PubMedPubMedCentralCrossRef
47.
Wright CM, Moorin RE, Chowdhury EK, Stricker BH, Reid CM, Saunders CM, et al. Calcium channel blockers and breast cancer incidence: an updated systematic review and meta-analysis of the evidence. Cancer Epidemiol. 2017;50(Pt A):113–24.PubMedCrossRef
48.
49.
50.
Jeong SM, Lee DH, Giovannucci EL. Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study. Eur J Epidemiol. 2019;34(12):1151–60.PubMedCrossRefPubMedCentral
51.
Lundberg FE, Johansson ALV, Rodriguez-Wallberg K, Gemzell-Danielsson K, Iliadou AN. Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. Eur J Epidemiol. 2019;34(11):1093–101.PubMedPubMedCentralCrossRef
52.
Renehan AG, Alam NN, Sperrin M. Interaction between co-morbidities and cancer survival. Eur J Epidemiol. 2019;34(11):1103–5.PubMedCrossRef
53.
Solberg S, Nilssen Y, Brustugun OT, Grimsrud TK, Haram PM, Helbekkmo N, et al. Increase in curative treatment and survival of lung cancer in Norway 2001–2016. Eur J Epidemiol. 2019;34(10):951–5.PubMedCrossRef
54.
Trocchi P, Kuss O, Kaab-Sanyal V, Heidinger O, Stang A. Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program. Eur J Epidemiol. 2019;34(12):1143–50.PubMedCrossRef
55.
56.
57.
Yang TO, Cairns BJ, Green J, Reeves GK, Floud S, Bradbury KE, et al. Adult cancer risk in women who were breastfed as infants: large UK prospective study. Eur J Epidemiol. 2019;34(9):863–70.PubMedPubMedCentralCrossRef
58.
Borch KB, Weiderpass E, Braaten T, Hansen MS, Licaj I. Risk of lung cancer and physical activity by smoking status and body mass index, the Norwegian Women and Cancer Study. Eur J Epidemiol. 2019;34(5):489–98.PubMedCrossRef
59.
Kar SP, Andrulis IL, Brenner H, Burgess S, Chang-Claude J, Considine D, et al. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. Eur J Epidemiol. 2019;34(6):591–600.PubMedPubMedCentralCrossRef
60.
Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur J Epidemiol. 2019;34(5):499–507.PubMedPubMedCentralCrossRef
61.
62.
Badrick E, Renehan I, Renehan AG. Linkage of the UK Clinical Practice Research Datalink with the national cancer registry. Eur J Epidemiol. 2019;34(1):101–2.PubMedCrossRef
63.
Erren TC, Lewis P. Hypothesis: ubiquitous circadian disruption can cause cancer. Eur J Epidemiol. 2019;34(1):1–4.PubMedCrossRef
64.
Kreis C, Doessegger E, Lupatsch JE, Spycher BD. Space-time clustering of childhood cancers: a systematic review and pooled analysis. Eur J Epidemiol. 2019;34(1):9–21.PubMedCrossRef
65.
Leoncini E, Vukovic V, Cadoni G, Giraldi L, Pastorino R, Arzani D, et al. Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium. Eur J Epidemiol. 2018;33(12):1205–18.PubMedPubMedCentralCrossRef
66.
Lorenz E, Scholz-Kreisel P, Baaken D, Pokora R, Blettner M. Radiotherapy for childhood cancer and subsequent thyroid cancer risk: a systematic review. Eur J Epidemiol. 2018;33(12):1139–62.PubMedCrossRef
67.
Mohner M. The Diesel Exhaust in Miners Study provides no evidence for an increase in risk for lung cancer in miners exposed to diesel engine emissions. Eur J Epidemiol. 2018;33(12):1251–4.PubMedPubMedCentralCrossRef
68.
Sandvei MS, Vatten LJ, Bjelland EK, Eskild A, Hofvind S, Ursin G, et al. Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life. Eur J Epidemiol. 2019;34(3):267–78.PubMedCrossRef
69.
Vitellius C, Laly M, Banaszuk AS, Deherce I, Cornet N, Bertrais S, et al. Contribution of the OC Sensor((R)) immunoassay in comparison to the Hemoccult II (R) guaiac-test in organized colorectal cancer screening. Eur J Epidemiol. 2019;34(2):163–72.PubMedCrossRef
70.
Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, et al. Circulating 25-hydroxyvitamin D up to 3decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol. 2018;33(11):1087–99.PubMedPubMedCentralCrossRef
71.
Zamora-Ros R, Cayssials V, Jenab M, Rothwell JA, Fedirko V, Aleksandrova K, et al. Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Eur J Epidemiol. 2018;33(11):1063–75.PubMedPubMedCentralCrossRef
72.
Petridou ET, Georgakis MK, Erdmann F, Ma XM, Heck JE, Auvinen A, et al. Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium. Eur J Epidemiol. 2018;33(10):965–76.PubMedPubMedCentralCrossRef
73.
Cordina-Duverger E, Menegaux F, Popa A, Rabstein S, Harth V, Pesch B, et al. Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history. Eur J Epidemiol. 2018;33(4):369–79.PubMedCrossRef
74.
75.
Hanley JA, Njor SH. Disaggregating the mortality reductions due to cancer screening: model-based estimates from population-based data. Eur J Epidemiol. 2018;33(5):465–72.PubMedCrossRef
76.
Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies. Eur J Epidemiol. 2018;33(5):473–84.PubMedPubMedCentralCrossRef
77.
Shield KD, Micallef CM, de Martel C, Heard I, Megraud F, Plummer M, et al. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(3):263–74.PubMedCrossRef
78.
Stang A, Jockel KH, Heidinger O. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000–2015). Eur J Epidemiol. 2018;33(3):303–12.PubMedCrossRef
79.
Wong MCS, Chan CH, Cheung W, Fung DH, Liang MY, Huang JLW, et al. Association between investigator-measured body-mass index and colorectal adenoma: a systematic review and meta-analysis of 168,201 subjects. Eur J Epidemiol. 2018;33(1):15–26.PubMedCrossRef
80.
Sun YQ, Langhammer A, Wu CS, Skorpen F, Chen Y, Nilsen TIL, et al. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study. Eur J Epidemiol. 2018;33(1):67–77.PubMedCrossRef
81.
Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012;27(3):173–85.PubMedPubMedCentralCrossRef
82.
Ligthart S, Sedaghat S, Ikram MA, Hofman A, Franco OH, Dehghan A. EN-RAGE: a novel inflammatory marker for incident coronary heart disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2695–9.PubMedCrossRef
83.
Brahimaj A, Ligthart S, Ghanbari M, Ikram MA, Hofman A, Franco OH, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217–26.PubMedPubMedCentralCrossRef
84.
Aslibekyan S, Agha G, Colicino E, Do AN, Lahti J, Ligthart S, et al. Association of methylation signals with incident coronary heart disease in an epigenome-wide assessment of circulating tumor necrosis factor alpha. JAMA Cardiol. 2018;3(6):463–72.PubMedPubMedCentralCrossRef
85.
Brahimaj A, Ligthart S, Ikram MA, Hofman A, Franco OH, Sijbrands EJ, et al. Serum levels of apolipoproteins and incident type 2 diabetes: a prospective cohort study. Diabetes Care. 2017;40(3):346–51.PubMedCrossRef
86.
Brahimaj A, Rivadeneira F, Muka T, Sijbrands EJG, Franco OH, Dehghan A, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62(9):1581–90.PubMedPubMedCentralCrossRef
87.
Nano J, Muka T, Ligthart S, Hofman A, Darwish Murad S, Janssen HLA, et al. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol. 2017;46(5):1400–9.PubMedCrossRef
88.
Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, et al. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood. 2015;126(25):2739–46.PubMedCrossRef
89.
Sonneveld MA, Franco OH, Ikram MA, Hofman A, Kavousi M, de Maat MP, et al. Von willebrand factor, ADAMTS13, and the risk of mortality: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2016;36(12):2446–511.PubMedCrossRef
90.
Sonneveld MA, Kavousi M, Ikram MA, Hofman A, Rueda Ochoa OL, Turecek PL, et al. Low ADAMTS-13 activity and the risk of coronary heart disease—a prospective cohort study: the Rotterdam Study. J Thromb Haemost. 2016;14(11):2114–200.PubMedCrossRef
91.
de Vries PS, van Herpt TT, Ligthart S, Hofman A, Ikram MA, van Hoek M, et al. ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study. Diabetologia. 2017;60(2):280–6.PubMedCrossRef
92.
Ward-Caviness CK, de Vries PS, Wiggins KL, Huffman JE, Yanek LR, Bielak LF, et al. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease. PLoS ONE. 2019;14(5):e0216222.PubMedPubMedCentralCrossRef
93.
Roselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018;50(9):1225–333.PubMedPubMedCentralCrossRef
94.
Liu CT, Merino J, Rybin D, DiCorpo D, Benke KS, Bragg-Gresham JL, et al. Genome-wide Association Study of Change in Fasting Glucose over time in 13,807 non-diabetic European Ancestry Individuals. Sci Rep. 2019;9(1):9439.PubMedPubMedCentralCrossRef
95.
Wild PS, Felix JF, Schillert A, Teumer A, Chen MH, Leening MJG, et al. Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest. 2017;127(5):1798–812.PubMedPubMedCentralCrossRef
96.
Liu J, Carnero-Montoro E, van Dongen J, Lent S, Nedeljkovic I, Ligthart S, et al. An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis. Nat Commun. 2019;10(1):2581.PubMedPubMedCentralCrossRef
97.
Ligthart S, Steenaard RV, Peters MJ, van Meurs JB, Sijbrands EJ, Uitterlinden AG, et al. Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes. Diabetologia. 2016;59(5):998–1006.PubMedPubMedCentralCrossRef
98.
t Hart LM, Vogelzangs N, Mook-Kanamori DO, Brahimaj A, Nano J, van der Heijden A, et al. Blood metabolomic measures associate with present and future glycemic control in type 2 diabetes. J Clin Endocrinol Metab. 2018;103(12):4569–79.CrossRef
99.
Sung YJ, de Las FL, Winkler TW, Chasman DI, Bentley AR, Kraja AT, et al. A multi-ancestry genome-wide study incorporating gene-smoking interactions identifies multiple new loci for pulse pressure and mean arterial pressure. Hum Mol Genet. 2019;28:2615–33.CrossRefPubMedPubMedCentral
100.
Sung YJ, Winkler TW, de Las FL, Bentley AR, Brown MR, Kraja AT, et al. A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Am J Hum Genet. 2018;102(3):375–400.PubMedPubMedCentralCrossRef
101.
Weng LC, Lunetta KL, Muller-Nurasyid M, Smith AV, Theriault S, Weeke PE, et al. Genetic interactions with age, sex, body mass index, and hypertension in relation to atrial fibrillation: the AFGen consortium. Sci Rep. 2017;7(1):11303.PubMedPubMedCentralCrossRef
102.
Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.PubMedPubMedCentralCrossRef
103.
Kavousi M, Desai CS, Ayers C, Blumenthal RS, Budoff MJ, Mahabadi AA, et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA. 2016;316(20):2126–34.PubMedCrossRef
104.
Jaspers L, Dhana K, Muka T, Meun C, Kiefte-de Jong JC, Hofman A, et al. Sex steroids, sex hormone-binding globulin and cardiovascular health in men and postmenopausal women: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(7):2844–52.PubMedCrossRef
105.
Glisic M, Mujaj B, Rueda-Ochoa OL, Asllanaj E, Laven JSE, Kavousi M, et al. Associations of endogenous estradiol and testosterone levels with plaque composition and risk of stroke in subjects with carotid atherosclerosis. Circ Res. 2018;122(1):97–105.PubMedCrossRef
106.
Brahimaj A, Muka T, Kavousi M, Laven JS, Dehghan A, Franco OH. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study. Diabetologia. 2017;60(1):98–106.PubMedCrossRef
107.
Muka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A, et al. Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes. 2017;66(3):577–86.PubMedCrossRef
108.
Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod. 2015;30(10):2376–86.PubMedCrossRef
109.
Daan NM, Muka T, Koster MP, Roeters van Lennep JE, Lambalk CB, Laven JS, et al. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J Clin Endocrinol Metab. 2016;101(9):3306–15.PubMedCrossRef
110.
Meun C, Franco OH, Dhana K, Jaspers L, Muka T, Louwers Y, et al. High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103(4):1622–30.PubMedCrossRef
111.
Muka T, Asllanaj E, Avazverdi N, Jaspers L, Stringa N, Milic J, et al. Age at natural menopause and risk of type 2 diabetes: a prospective cohort study. Diabetologia. 2017;60(10):1951–60.PubMedPubMedCentralCrossRef
112.
Asllanaj E, Bano A, Glisic M, Jaspers L, Ikram MA, Laven JSE, et al. Age at natural menopause and life expectancy with and without type 2 diabetes. Menopause. 2019;26(4):387–94.PubMedCrossRef
113.
Sarnowski C, Kavousi M, Isaacs S, Demerath EW, Broer L, Muka T, et al. Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women. Menopause. 2018;25(4):451–7.PubMedPubMedCentralCrossRef
114.
Rueda-Ochoa OL, Smiderle-Gelain MA, Rizopoulos D, Dhana K, van den Berge JK, Echeverria LE, et al. Risk factors for longitudinal changes in left ventricular diastolic function among women and men. Heart. 2019;105(18):1414–22.PubMedCrossRef
115.
Jaspers L, Schoufour JD, Erler NS, Darweesh SK, Portegies ML, Sedaghat S, et al. Development of a healthy aging score in the population-based rotterdam study: evaluating age and sex differences. J Am Med Dir Assoc. 2017;18(3):276e1–e7.CrossRef
116.
Jaspers L, Kavousi M, Erler NS, Hofman A, Laven JS, Franco OH. Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study. Fertil Steril. 2017;107(2):448–56e1.PubMedCrossRef
117.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–53.PubMedCrossRef
118.
Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):44–51.PubMedCrossRef
119.
Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311(14):1416–23.PubMedCrossRef
120.
Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44.PubMedCrossRef
121.
Yano Y, O'Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol. 2017;2(9):986–94.PubMedPubMedCentralCrossRef
122.
Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, et al. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019;40(7):621–31.PubMedCrossRef
123.
Group WCRCW. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7:1332–455.CrossRef
124.
Dhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2015;101(5):377–83.PubMedCrossRef
125.
Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E, et al. Use of repeated blood pressure and cholesterol measurements to improve cardiovascular disease risk prediction: an individual-participant-data meta-analysis. Am J Epidemiol. 2017;186(8):899–907.PubMedPubMedCentralCrossRef
126.
Cho IJ, Sung JM, Kim HC, Lee SE, Chae MH, Kavousi M, et al. Development and External Validation of a Deep Learning Algorithm for Prognostication of Cardiovascular Outcomes. Korean Circ J. 2019;50:72–84.PubMedPubMedCentralCrossRef
127.
Wen KX, Ikram MA, Franco OH, Vernooij M, MaassenVanDenBrink A, Bos D, et al. Association of migraine with calcification in major vessel beds: the Rotterdam Study. Cephalalgia. 2019;39(8):1041–8.PubMedCrossRef
128.
Sedaghat S, Hoorn EJ, Ikram MA, Koop-Nieuwelink C, Kavousi M, Franco OH, et al. Kidney function and arterial calcification in major vascular beds. J Am Heart Assoc. 2019;8(9):e010930.PubMedPubMedCentralCrossRef
129.
Chen LY, Leening MJ, Norby FL, Roetker NS, Hofman A, Franco OH, et al. Carotid intima-media thickness and arterial stiffness and the risk of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study. J Am Heart Assoc. 2016;5(5):002907. https://​doi.​org/​10.​1161/​JAHA.​115.​002907. CrossRef
130.
Bos D, Vernooij MW, Shahzad R, Kavousi M, Hofman A, van Walsum T, et al. Epicardial fat volume and the risk of atrial fibrillation in the general population free of cardiovascular disease. JACC Cardiovasc Imaging. 2017;10(11):1405–7.PubMedCrossRef
131.
Croll PH, Bos D, Vernooij MW, Arshi B, Lin FR, Baatenburg de Jong RJ, et al. Carotid atherosclerosis is associated with poorer hearing in older adults. J Am Med Dir Assoc. 2019;20(12):1617–22e1.CrossRef
132.
Sedaghat S, van Sloten TT, Laurent S, London GM, Pannier B, Kavousi M, et al. Common carotid artery diameter and risk of cardiovascular events and mortality: pooled analyses of four cohort studies. Hypertension. 2018;72(1):85–92.PubMedCrossRef
133.
Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, et al. Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk—results from the PROG-IMT collaboration. PLoS ONE. 2018;13(4):e0191172.PubMedPubMedCentralCrossRef
134.
Nilsson PM, Laurent S, Cunha PG, Olsen MH, Rietzschel E, Franco OH, et al. Characteristics of healthy vascular ageing in pooled population-based cohort studies: the global Metabolic syndrome and Artery REsearch Consortium. J Hypertens. 2018;36(12):2340–9.PubMedPubMedCentralCrossRef
135.
Mujaj B, Bos D, Selwaness M, Leening MJG, Kavousi M, Wentzel JJ, et al. Statin use is associated with carotid plaque composition: the Rotterdam Study. Int J Cardiol. 2018;260:213–8.PubMedCrossRef
136.
van den Bouwhuijsen QJ, Selwaness M, Tang H, Niessen WJ, Hofman A, Franco OH, et al. Change in carotid intraplaque hemorrhage in community-dwelling subjects: a follow-up study using serial MR imaging. Radiology. 2017;282(2):526–33.PubMedCrossRef
137.
Mujaj B, Bos D, Muka T, Lugt AV, Ikram MA, Vernooij MW, et al. Antithrombotic treatment is associated with intraplaque haemorrhage in the atherosclerotic carotid artery: a cross-sectional analysis of The Rotterdam Study. Eur Heart J. 2018;39(36):3369–76.PubMedPubMedCentralCrossRef
138.
Franceschini N, Giambartolomei C, de Vries PS, Finan C, Bis JC, Huntley RP, et al. GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes. Nat Commun. 2018;9(1):5141.PubMedPubMedCentralCrossRef
139.
Natarajan P, Bis JC, Bielak LF, Cox AJ, Dorr M, Feitosa MF, et al. Multiethnic exome-wide association study of subclinical atherosclerosis. Circ Cardiovasc Genet. 2016;9(6):511–20.PubMedPubMedCentralCrossRef
140.
Tzoulaki I, Castagne R, Boulange CL, Karaman I, Chekmeneva E, Evangelou E, et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. Eur Heart J. 2019;40(34):2883–96.PubMedCrossRefPubMedCentral
141.
Vojinovic D, van der Lee SJ, van Duijn CM, Vernooij MW, Kavousi M, Amin N, et al. Metabolic profiling of intra- and extracranial carotid artery atherosclerosis. Atherosclerosis. 2018;272:60–5.PubMedCrossRef
142.
143.
Kunutsor SK, Mäkikallio TH, Khan H, Laukkanen T, Kauhanen J, Laukkanen JA. Sauna bathing reduces the risk of venous thromboembolism: a prospective cohort study. Eur J Epidemiol. 2019;34(10):983–6.PubMedCrossRef
144.
Wu L, Lin HD, Hu Y, Zhu CW, Ma H, Gao J, et al. The major causes and risk factors of total and cause-specific mortality during 5.4-year follow-up: the Shanghai Changfeng Study. Eur J Epidemiol. 2019;34(10):939–49.PubMedPubMedCentralCrossRef
145.
Fest J, Ruiter TR, Koerkamp BG, Rizopoulos D, Ikram MA, van Eijck CHJ, et al. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam Study. Eur J Epidemiol. 2019;34(5):463–70.PubMedCrossRef
146.
Hamer M, O'Donovan G, Stamatakis E. Association between physical activity and sub-types of cardiovascular disease death causes in a general population cohort. Eur J Epidemiol. 2019;34(5):483–7.PubMedCrossRef
147.
Kobeissi E, Hibino M, Pan H, Aune D. Blood pressure, hypertension and the risk of abdominal aortic aneurysms: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2019;34(6):547–55.PubMedPubMedCentralCrossRef
148.
Xuan Y, Bobak M, Anusruti A, Jansen E, Pajak A, Tamosiunas A, et al. Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies. Eur J Epidemiol. 2019;34(5):471–81.PubMedCrossRef
149.
Meier T, Grafe K, Senn F, Sur P, Stangl GI, Dawczynski C, et al. Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: a systematic analysis of the Global Burden of Disease Study. Eur J Epidemiol. 2019;34(1):37–55.PubMedCrossRef
150.
Zhu DS, Chung HF, Pandeya N, Dobson AJ, Hardy R, Kuh D, et al. Premenopausal cardiovascular disease and age at natural menopause: a pooled analysis of over 170,000 women. Eur J Epidemiol. 2019;34(3):235–46.PubMedCrossRef
151.
Aune D, Schlesinger S, Norat T, Riboli E. Body mass index, abdominal fatness, and the risk of sudden cardiac death: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2018;33(8):711–22.PubMedPubMedCentralCrossRef
152.
Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2018;33(6):509–21.PubMedPubMedCentralCrossRef
153.
Bergen NE, Schalekamp-Timmermans S, van Lennep JER, Jaddoe VVW, Steegers EAP. Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health. Eur J Epidemiol. 2018;33(8):763–71.PubMedPubMedCentralCrossRef
154.
Haug EB, Horn J, Markovitz AR, Fraser A, Macdonald-Wallis C, Tilling K, et al. The impact of parity on life course blood pressure trajectories: the HUNT study in Norway. Eur J Epidemiol. 2018;33(8):751–61.PubMedPubMedCentralCrossRef
155.
Timpka S, Fraser A, Schyman T, Stuart JJ, Asvold BO, Mogren I, et al. The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women. Eur J Epidemiol. 2018;33(10):1003–100.PubMedPubMedCentralCrossRef
156.
Wannamethee SG, Papacosta O, Lennon L, Whincup PH. Serum magnesium and risk of incident heart failure in older men: the British Regional Heart Study. Eur J Epidemiol. 2018;33(9):873–82.PubMedPubMedCentralCrossRef
157.
Billar RJ, Leening MJG, Merkus D, Brusselle GGO, Hofman A, Stricker BHC, et al. Measures of subclinical cardiac dysfunction and increased filling pressures associate with pulmonary arterial pressure in the general population: results from the population-based Rotterdam Study. Eur J Epidemiol. 2018;33(4):403–13.PubMedCrossRef
158.
Floegel A, Kuhn T, Sookthai D, Johnson T, Prehn C, Rolle-Kampczyk U, et al. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts. Eur J Epidemiol. 2018;33(1):55–66.PubMedCrossRef
159.
Hantikainen E, Lof M, Grotta A, Lagerros YT, Serafini M, Bellocco R, et al. Dietary non enzymatic antioxidant capacity and the risk of myocardial infarction in the Swedish women's lifestyle and health cohort. Eur J Epidemiol. 2018;33(2):213–21.PubMedCrossRef
160.
Jones NRV, Forouhi NG, Khaw KT, Wareham NJ, Monsivais P. Accordance to the Dietary Approaches to Stop Hypertension diet pattern and cardiovascular disease in a British, population-based cohort. Eur J Epidemiol. 2018;33(2):235–44.PubMedPubMedCentralCrossRef
161.
Pardo LM, Li WQ, Hwang SJ, Verkouteren JA, Hofman A, Uitterlinden AG, et al. Genome-wide association studies of multiple keratinocyte cancers. PLoS ONE. 2017;12(1):e0169873.PubMedPubMedCentralCrossRef
162.
Smedinga H, Verkouteren JAC, Steyerberg EW, Hofman A, Nijsten T, Vergouwe Y. Occurrence of metachronous basal cell carcinomas: a prognostic model. Br J Dermatol. 2017;177(4):1113–21.PubMedCrossRef
163.
Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, et al. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nat Commun. 2018;9(1):4774.PubMedPubMedCentralCrossRef
164.
Jacobs LC, Liu F, Pardo LM, Hofman A, Uitterlinden AG, Kayser M, et al. IRF4, MC1R and TYR genes are risk factors for actinic keratosis independent of skin color. Hum Mol Genet. 2015;24(11):3296–303.PubMedCrossRef
165.
Tagliabue E, Fargnoli MC, Gandini S, Maisonneuve P, Liu F, Kayser M, et al. MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project. Br J Cancer. 2015;113(2):354–63.PubMedPubMedCentralCrossRef
166.
Zhong K, Verkouteren JAC, Jacobs LC, Uitterlinden AG, Hofman A, Liu F, et al. Pigmentation-independent susceptibility loci for actinic keratosis highlighted by compound heterozygosity analysis. J Invest Dermatol. 2017;137(1):77–84.PubMedCrossRef
167.
Liu F, Hamer MA, Heilmann S, Herold C, Moebus S, Hofman A, et al. Prediction of male-pattern baldness from genotypes. Eur J Hum Genet. 2016;24(6):895–902.PubMedCrossRef
168.
Liu F, Hamer MA, Deelen J, Lall JS, Jacobs L, van Heemst D, et al. The MC1R gene and youthful looks. Curr Biol. 2016;26(9):1213–20.PubMedCrossRef
169.
Zhong K, Zhu G, Jing X, Hendriks AEJ, Drop SLS, Ikram MA, et al. Genome-wide compound heterozygote analysis highlights alleles associated with adult height in Europeans. Hum Genet. 2017;136(11–12):1407–17.PubMedPubMedCentralCrossRef
170.
Hysi PG, Valdes AM, Liu F, Furlotte NA, Evans DM, Bataille V, et al. Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability. Nat Genet. 2018;50(5):652–6.PubMedPubMedCentralCrossRef
171.
Liu F, Chen Y, Zhu G, Hysi PG, Wu S, Adhikari K, et al. Meta-analysis of genome-wide association studies identifies 8 novel loci involved in shape variation of human head hair. Hum Mol Genet. 2018;27(3):559–75.PubMedCrossRef
172.
Visconti A, Duffy DL, Liu F, Zhu G, Wu W, Chen Y, et al. Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposure. Nat Commun. 2018;9(1):1684.PubMedPubMedCentralCrossRef
173.
Wu S, Zhang M, Yang X, Peng F, Zhang J, Tan J, et al. Genome-wide association studies and CRISPR/Cas9-mediated gene editing identify regulatory variants influencing eyebrow thickness in humans. PLoS Genet. 2018;14(9):e1007640.PubMedPubMedCentralCrossRef
174.
Peng F, Zhu G, Hysi PG, Eller RJ, Chen Y, Li Y, et al. Genome-wide association studies identify multiple genetic loci influencing eyebrow color variation in Europeans. J Invest Dermatol. 2019;139(7):1601–5.PubMedCrossRef
175.
Hamer MA, Pardo LM, Jacobs LC, Ikram MA, Laven JS, Kayser M, et al. Lifestyle and physiological factors associated with facial wrinkling in men and women. J Invest Dermatol. 2017;137(8):1692–9.PubMedCrossRef
176.
Hamer MA, Pardo LM, Jacobs LC, Deelen J, Uitterlinden AG, Slagboom E, et al. Facial wrinkles in Europeans: a Genome-Wide Association Study. J Invest Dermatol. 2018;138(8):1877–80.PubMedCrossRef
177.
Mekic S, Jacobs LC, Hamer MA, Ikram MA, Schoufour JD, Gunn DA, et al. A healthy diet in women is associated with less facial wrinkles in a large Dutch population-based cohort. J Am Acad Dermatol. 2019;80(5):1358–63.PubMedCrossRef
178.
179.
Sanders MGH, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study. Br J Dermatol. 2018;178(1):148–53.PubMedCrossRef
180.
Sanders MGH, Pardo LM, Uitterlinden AG, Smith AM, Ginger RS, Nijsten T. The genetics of seborrheic dermatitis: a candidate gene approach and pilot Genome-Wide Association Study. J Invest Dermatol. 2018;138(4):991–3.PubMedCrossRef
181.
Aune D, Snekvik I, Schlesinger S, Norat T, Riboli E, Vatten LJ. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2018;33(12):1163–78.PubMedPubMedCentralCrossRef
182.
Chaker L, van den Berg ME, Niemeijer MN, Franco OH, Dehghan A, Hofman A, et al. Thyroid function and sudden cardiac death: a prospective population-based cohort study. Circulation. 2016;134(10):713–22.PubMedCrossRef
183.
Bano A, Chaker L, Mattace-Raso FUS, van der Lugt A, Ikram MA, Franco OH, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam Study. Circ Res. 2017;121(12):1392–400.PubMedCrossRef
184.
Chaker L, Wolters FJ, Bos D, Korevaar TI, Hofman A, van der Lugt A, et al. Thyroid function and the risk of dementia: the Rotterdam Study. Neurology. 2016;87(16):1688–95.PubMedCrossRef
185.
Bano A, Chaker L, Schoufour J, Ikram MA, Kavousi M, Franco OH, et al. High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103(1):328–35.PubMedCrossRef
186.
Chaker L, Ligthart S, Korevaar TI, Hofman A, Franco OH, Peeters RP, et al. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med. 2016;14(1):150.PubMedPubMedCentralCrossRef
187.
Bano A, Chaker L, de Maat MPM, Atiq F, Kavousi M, Franco OH, et al. Thyroid function and cardiovascular disease: the mediating role of coagulation factors. J Clin Endocrinol Metab. 2019;104(8):3203–12.PubMedCrossRef
188.
Bano A, Dhana K, Chaker L, Kavousi M, Ikram MA, Mattace-Raso FUS, et al. Association of thyroid function with life expectancy with and without cardiovascular disease: the Rotterdam Study. JAMA Intern Med. 2017;177(11):1650–7.PubMedPubMedCentralCrossRef
189.
Teumer A, Chaker L, Groeneweg S, Li Y, Di Munno C, Barbieri C, et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat Commun. 2018;9(1):4455.PubMedPubMedCentralCrossRef
190.
Chaker L, Cappola AR, Mooijaart SP, Peeters RP. Clinical aspects of thyroid function during ageing. Lancet Diabetes Endocrinol. 2018;6(9):733–42.PubMedCrossRef
191.
192.
193.
Koop-Nieuwelink C, Sedaghat S, Mutlu U, Licher S, Franco OH, Ikram MA, et al. Kidney function and the risk of stroke and dementia: the Rotterdam Study. J Alzheimers Dis. 2019;67(3):821–6.PubMedCrossRef
194.
Sedaghat S, Vernooij MW, Loehrer E, Mattace-Raso FU, Hofman A, van der Lugt A, et al. Kidney function and cerebral blood flow: the Rotterdam Study. J Am Soc Nephrol. 2016;27(3):715–21.PubMedCrossRef
195.
Sedaghat S, Cremers LG, de Groot M, Hoorn EJ, Hofman A, van der Lugt A, et al. Kidney function and microstructural integrity of brain white matter. Neurology. 2015;85(2):154–61.PubMedCrossRef
196.
Sedaghat S, de Vries PS, Boender J, Sonneveld MA, Hoorn EJ, Hofman A, et al. von Willebrand factor, ADAMTS13 activity, and decline in kidney function: a population-based cohort study. Am J Kidney Dis. 2016;68(5):726–32.PubMedCrossRef
197.
Li WZ, Chen ZL, Ruan WY, Yi GL, Wang DM, Lu ZX. A meta-analysis of cohort studies including dose-response relationship between shift work and the risk of diabetes mellitus. Eur J Epidemiol. 2019;34(11):1013–24.PubMedCrossRef
198.
Neuenschwander M, Hoffmann G, Schwingshackl L, Schlesinger S. Impact of different dietary approaches on blood lipid control in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Eur J Epidemiol. 2019;34(9):837–52.PubMedCrossRef
199.
van der Schaft N, Schoufour JD, Nano J, Kiefte-de Jong JC, Muka T, Sijbrands EJG, et al. Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study. Eur J Epidemiol. 2019;34(9):853–61.PubMedPubMedCentralCrossRef
200.
Chen JL, van der Duin D, Campos-Obando N, Ikram MA, Nijsten TEC, Uitterlinden AG, et al. Serum 25-hydroxyvitamin D-3 is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: the Rotterdam Study. Eur J Epidemiol. 2019;34(1):67–77.PubMedCrossRef
201.
Choi YJ, Lee DH, Han KD, Shin CM, Kim N. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer. Eur J Epidemiol. 2018;33(11):1077–85.PubMedCrossRef
202.
Huth C, von Toerne C, Schederecker F, Gala TD, Herder C, Kronenberg F, et al. Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study. Eur J Epidemiol. 2019;34(4):409–22.PubMedCrossRef
203.
Saarela K, Tuomilehto J, Sund R, Keskimaki I, Hartikainen S, Pukkala E. Cancer incidence among Finnish people with type 2 diabetes during 1989–2014. Eur J Epidemiol. 2019;34(3):259–65.PubMedCrossRef
204.
Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033–47.PubMedPubMedCentralCrossRef
205.
Chen ZL, Zuurmond MG, van der Schaft N, Nano J, Wijnhoven HAH, Ikram MA, et al. Plant versus animal based diets and insulin resistance, prediabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2018;33(9):883–93.PubMedPubMedCentralCrossRef
206.
Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, et al. Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women. Eur J Epidemiol. 2018;33(11):1113–23.PubMedCrossRef
207.
Vinceti M, Filippini T, Rothman KJ. Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):789–810.PubMedCrossRef
208.
Schwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H. A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol. 2018;33(2):157–70.PubMedPubMedCentralCrossRef
209.
Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32(9):807–50.PubMedPubMedCentralCrossRef
210.
Florio AA, Graubard BI, Yang B, Thistle JE, Bradley MC, McGlynn KA, et al. Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. Eur J Epidemiol. 2019;34(9):871–8.PubMedCrossRefPubMedCentral
211.
Marild K, Tapia G, Midttun O, Ueland PM, Magnus MC, Rewers M, et al. Smoking in pregnancy, cord blood cotinine and risk of celiac disease diagnosis in offspring. Eur J Epidemiol. 2019;34(7):637–49.PubMedPubMedCentralCrossRef
212.
Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970–3.PubMedPubMedCentralCrossRef
213.
Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575–80.PubMedCrossRef
214.
de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143–6.PubMedCrossRef
215.
Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114(15):1591–8.PubMedCrossRef
216.
Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA. 2007;298(24):2877–85.PubMedCrossRef
217.
Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74(3):317–21.PubMedPubMedCentralCrossRef
218.
Ikram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, et al. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol. 2011;26(10):811–24.PubMedPubMedCentralCrossRef
219.
Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29(2):133–40.PubMedCrossRef
220.
Killgore WD, Glahn DC, Casasanto DJ. Development and Validation of the Design Organization Test (DOT): a rapid screening instrument for assessing visuospatial ability. J Clin Exp Neuropsychol. 2005;27(4):449–59.PubMedCrossRef
221.
Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.PubMedCrossRef
222.
Verlinden VJ, van der Geest JN, Hoogendam YY, Hofman A, Breteler MM, Ikram MA. Gait patterns in a community-dwelling population aged 50 years and older. Gait Posture. 2013;37(4):500–5.PubMedCrossRef
223.
Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87(18):1892–8.PubMedCrossRef
224.
Licher S, Darweesh SKL, Wolters FJ, Fani L, Heshmatollah A, Mutlu U, et al. Lifetime risk of common neurological diseases in the elderly population. J Neurol Neurosurg Psychiatry. 2019;90(2):148–56.PubMedCrossRef
225.
Wolters FJ, Tinga LM, Dhana K, Koudstaal PJ, Hofman A, Bos D, et al. Life Expectancy with and without dementia: a population-based study of dementia burden and preventive potential. Am J Epidemiol. 2019;188(2):372–81.PubMedCrossRef
226.
Licher S, Ahmad S, Karamujic-Comic H, Voortman T, Leening MJG, Ikram MA, et al. Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nat Med. 2019;25(9):1364–9.PubMedPubMedCentralCrossRef
227.
van der Lee SJ, Wolters FJ, Ikram MK, Hofman A, Ikram MA, Amin N, et al. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. Lancet Neurol. 2018;17(5):434–44.PubMedCrossRef
228.
Licher S, Yilmaz P, Leening MJG, Wolters FJ, Vernooij MW, Stephan BCM, et al. External validation of four dementia prediction models for use in the general community-dwelling population: a comparative analysis from the Rotterdam Study. Eur J Epidemiol. 2018;33(7):645–55. PubMedPubMedCentralCrossRef
229.
Licher S, Leening MJG, Yilmaz P, Wolters FJ, Heeringa J, Bindels PJE, et al. Development and validation of a dementia risk prediction model in the general population: an analysis of three longitudinal studies. Am J Psychiatry. 2019;176(7):543–51.PubMedCrossRef
230.
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017;49(9):1373–84.PubMedPubMedCentralCrossRef
231.
Wolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij MW, et al. Cerebral perfusion and the risk of dementia: a population-based study. Circulation. 2017;136(8):719–28.PubMedCrossRef
232.
Wolters FJ, van der Lee SJ, Koudstaal PJ, van Duijn CM, Hofman A, Ikram MK, et al. Parental family history of dementia in relation to subclinical brain disease and dementia risk. Neurology. 2017;88(17):1642–9.PubMedCrossRef
233.
Licher S, van der Willik KD, Vinke EJ, Yilmaz P, Fani L, Schagen SB, et al. Alzheimer's disease as a multistage process: an analysis from a population-based cohort study. Aging (Albany NY). 2019;11(4):1163–76.CrossRef
234.
Mutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, Wolters FJ, et al. Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol. 2018;75(10):1256–63.PubMedPubMedCentralCrossRef
235.
Darweesh SKL, Licher S, Wolters FJ, Koudstaal PJ, Ikram MK, Ikram MA. Quantitative gait, cognitive decline, and incident dementia: The Rotterdam Study. Alzheimers Dement. 2019;15:1264–73.PubMedCrossRef
236.
Fani L, Bos D, Mutlu U, Portegies MLP, Zonneveld HI, Koudstaal PJ, et al. Global brain perfusion and the risk of transient ischemic attack and ischemic stroke: the Rotterdam Study. J Am Heart Assoc. 2019;8(7):e011565. PubMedPubMedCentralCrossRef
237.
Mutlu U, Swanson SA, Klaver CCW, Hofman A, Koudstaal PJ, Ikram MA, et al. The mediating role of the venules between smoking and ischemic stroke. Eur J Epidemiol. 2018;33(12):1219–28.PubMedPubMedCentralCrossRef
238.
Berghout BP, Fani L, Heshmatollah A, Koudstaal PJ, Ikram MA, Zillikens MC, et al. Vitamin D status and risk of stroke. Stroke. 2019;50(9):2293–8.PubMedCrossRef
239.
Bos D, Ikram MA, Leening MJG, Ikram MK. The revised framingham stroke risk profile in a primary prevention population: the Rotterdam Study. Circulation. 2017;135(22):2207–9.PubMedCrossRef
240.
Lysen TS, Darweesh SKL, Ikram MK, Luik AI, Ikram MA. Sleep and risk of parkinsonism and Parkinson's disease: a population-based study. Brain. 2019;142(7):2013–22.PubMedPubMedCentralCrossRef
241.
Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, et al. Association between poor cognitive functioning and risk of incident parkinsonism: the Rotterdam Study. JAMA Neurol. 2017;74(12):1431–8.PubMedPubMedCentralCrossRef
242.
Darweesh SK, Verlinden VJ, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA. Trajectories of prediagnostic functioning in Parkinson's disease. Brain. 2017;140(Pt 2):429–41.PubMedCrossRef
243.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414–30.PubMedPubMedCentralCrossRef
244.
Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, et al. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. Neurology. 2019;92:e486–e503.PubMedCentralCrossRef
245.
Vojinovic D, Adams HH, Jian X, Yang Q, Smith AV, Bis JC, et al. Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume. Nat Commun. 2018;9(1):3945.PubMedPubMedCentralCrossRef
246.
Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524–37.PubMedPubMedCentralCrossRef
247.
248.
249.
Binder N, Balmford J, Schumacher M. A multi-state model based reanalysis of the Framingham Heart Study: is dementia incidence really declining? Eur J Epidemiol. 2019;34(11):1075–83.PubMedCrossRef
250.
251.
Murley C, Friberg E, Hillert J, Alexanderson K, Yang F. Validation of multiple sclerosis diagnoses in the Swedish National Patient Register. Eur J Epidemiol. 2019;34(12):1161–9.PubMedPubMedCentralCrossRef
252.
Richardson C, Stephan BCM, Robinson L, Brayne C, Matthews FE, Cognitive Function Ageing S. Two-decade change in prevalence of cognitive impairment in the UK. Eur J Epidemiol. 2019;34(11):1085–92.PubMedPubMedCentralCrossRef
253.
Rist PM, Buring JE, Rexrode KM, Cook NR, Rost NS. Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients. Eur J Epidemiol. 2019;34(10):957–65.PubMedCrossRefPubMedCentral
254.
Sommerlad A, Perera G, Mueller C, Singh-Manoux A, Lewis G, Stewart R, et al. Hospitalisation of people with dementia: evidence from English electronic health records from 2008 to 2016. Eur J Epidemiol. 2019;34(6):567–77.PubMedPubMedCentralCrossRef
255.
Wilkinson T, Schnier C, Bush K, Rannikmae K, Henshall DE, Lerpiniere C, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557–65.PubMedPubMedCentralCrossRef
256.
Grasset L, Peres K, Joly P, Sabathe C, Foubert-Samier A, Dartigues JF, et al. Secular trends of mortality and dementia-free life expectancy over a 10-year period in France. Eur J Epidemiol. 2019;34(2):115–23.PubMedCrossRef
257.
Hayat SA, Luben R, Dalzell N, Moore S, Hogervorst E, Matthews FE, et al. Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality. Eur J Epidemiol. 2018;33(11):1049–62.PubMedPubMedCentralCrossRef
258.
Kobayashi LC, Berkman LF, Wagner RG, Kahn K, Tollman S, Subramanian SV. Education modifies the relationship between height and cognitive function in a cross-sectional population-based study of older adults in Rural South Africa. Eur J Epidemiol. 2019;34(2):131–9.PubMedCrossRef
259.
Li GW, Lip GYH, Holbrook A, Chang YP, Larsen TB, Sun X, et al. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. Eur J Epidemiol. 2019;34(2):173–90.PubMedCrossRef
260.
Nael V, Peres K, Dartigues JF, Letenneur L, Amieva H, Arleo A, et al. Vision loss and 12-year risk of dementia in older adults: the 3C cohort study. Eur J Epidemiol. 2019;34(2):141–52.PubMedCrossRef
261.
Osler M, Christensen GT, Mortensen EL, Christensen K, Garde E, Rozing MP. Hearing loss, cognitive ability, and dementia in men age 19–78 years. Eur J Epidemiol. 2019;34(2):125–30.PubMedCrossRef
262.
Bokenberger K, Sjolander A, Aslan AKD, Karlsson IK, Akerstedt T, Pedersen NL. Shift work and risk of incident dementia: a study of two population-based cohorts. Eur J Epidemiol. 2018;33(10):977–87.PubMedPubMedCentralCrossRef
263.
Darweesh SKL, Wolters FJ, Ikram MA, Bos D, Hofman A. Broadening the scope of epidemiologic dementia research. Eur J Epidemiol. 2018;33(7):617–20.PubMedCrossRef
264.
Evans S, McRae-McKee K, Wong MM, Hadjichrysanthou C, De Wolf F, Anderson R. The importance of endpoint selection: how effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment? Eur J Epidemiol. 2018;33(7):635–44.PubMedPubMedCentralCrossRef
265.
Glymour MM, Brickman AM, Kivimaki M, Mayeda ER, Chene G, Dufouil C, et al. Will biomarker-based diagnosis of Alzheimer's disease maximize scientific progress? Evaluating proposed diagnostic criteria. Eur J Epidemiol. 2018;33(7):607–12.CrossRefPubMedPubMedCentral
266.
Kuller LH. A new era for dementia epidemiology: Alzheimer's disease, hardening of arteries, or just old age? Eur J Epidemiol. 2018;33(7):613–6.PubMedCrossRef
267.
Marin B, Fontana A, Arcuti S, Copetti M, Boumediene F, Couratier P, et al. Age-specific ALS incidence: a dose-response meta-analysis. Eur J Epidemiol. 2018;33(7):621–34.PubMedCrossRef
268.
Ower AK, Hadjichrysanthou C, Gras L, Goudsmit J, Anderson RM, de Wolf F, et al. Temporal association patterns and dynamics of amyloid-beta and tau in Alzheimer's disease. Eur J Epidemiol. 2018;33(7):657–66.PubMedCrossRef
269.
Vangen-Lonne AM, Ueda P, Gulayin P, Wilsgaard T, Mathiesen EB, Danaei G. Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population. Eur J Epidemiol. 2018;33(6):557–66.PubMedCrossRef
270.
Vlaar T, Kab S, Schwaab Y, Frery N, Elbaz A, Moisan F. Association of Parkinson's disease with industry sectors: a French nationwide incidence study. Eur J Epidemiol. 2018;33(11):1101–11.PubMedCrossRef
271.
Wickstrom R, Skiold B, Petersson G, Stephansson O, Altman M. Moderate neonatal hypoglycemia and adverse neurological development at 2–6 years of age. Eur J Epidemiol. 2018;33(10):1011–20.PubMedPubMedCentralCrossRef
272.
Xue BW, Cadar D, Fleischmann M, Stansfeld S, Carr E, Kivimaki M, et al. Effect of retirement on cognitive function: the Whitehall II cohort study. Eur J Epidemiol. 2018;33(10):989–1001.PubMedCrossRef
273.
Bhushan A, Fondell E, Ascherio A, Yuan CZ, Grodstein F, Willett W. Adherence to Mediterranean diet and subjective cognitive function in men. Eur J Epidemiol. 2018;33(2):223–34.PubMedCrossRef
274.
Laursen ASD, Dahm CC, Johnsen SP, Tjonneland A, Overvad K, Jakobsen MU. Substitutions of dairy product intake and risk of stroke: a Danish cohort study. Eur J Epidemiol. 2018;33(2):201–12.PubMedCrossRef
275.
Thygesen SK, Olsen M, Pedersen L, Henderson VW, Ostergaard JR, Sorensen HT. Respiratory distress syndrome in preterm infants and risk of epilepsy in a Danish cohort. Eur J Epidemiol. 2018;33(3):313–21.PubMedCrossRef
276.
Fondell E, Townsend MK, Unger LD, Okereke OI, Grodstein F, Ascherio A, et al. Physical activity across adulthood and subjective cognitive function in older men. Eur J Epidemiol. 2018;33(1):79–877.PubMedCrossRef
277.
Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, et al. Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology. 2017;124(12):1753–63.PubMedCrossRef
278.
Colijn JM, den Hollander AI, Demirkan A, Cougnard-Gregoire A, Verzijden T, Kersten E, et al. Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European Eye Epidemiology Consortia. Ophthalmology. 2019;126(3):393–406.PubMedCrossRef
279.
Corominas J, Colijn JM, Geerlings MJ, Pauper M, Bakker B, Amin N, et al. Whole-exome sequencing in age-related macular degeneration identifies rare variants in COL8A1, a component of Bruch's Membrane. Ophthalmology. 2018;125(9):1433–43.PubMedCrossRef
280.
Merle BMJ, Colijn JM, Cougnard-Gregoire A, de Koning-Backus APM, Delyfer MN, Kiefte-de Jong JC, et al. Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK Consortium. Ophthalmology. 2019;126(3):381–90.PubMedCrossRef
281.
Joachim N, Kifley A, Colijn JM, Lee KE, Buitendijk GHS, Klein BEK, et al. Joint contribution of genetic susceptibility and modifiable factors to the progression of age-related macular degeneration over 10 years: the three continent AMD consortium report. Ophthalmol Retina. 2018;2(7):684–93.PubMedCrossRef
282.
de Koning-Backus APM, Buitendijk GHS, Kiefte-de Jong JC, Colijn JM, Hofman A, Vingerling JR, et al. Intake of vegetables, fruit, and fish is beneficial for age-related macular degeneration. Am J Ophthalmol. 2019;198:70–9.PubMedCrossRef
283.
Tedja MS, Wojciechowski R, Hysi PG, Eriksson N, Furlotte NA, Verhoeven VJM, et al. Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error. Nat Genet. 2018;50(6):834–48.PubMedPubMedCentralCrossRef
284.
Tideman JW, Snabel MC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RW, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134(12):1355–63.PubMedCrossRef
285.
Aschard H, Kang JH, Iglesias AI, Hysi P, Cooke Bailey JN, Khawaja AP, et al. Genetic correlations between intraocular pressure, blood pressure and primary open-angle glaucoma: a multi-cohort analysis. Eur J Hum Genet. 2017;25(11):1261–7.PubMedPubMedCentralCrossRef
286.
Iglesias AI, Ong JS, Khawaja AP, Gharahkhani P, Tedja MS, Verhoeven VJM, et al. Determining possible shared genetic architecture between myopia and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2019;60(8):3142–9.PubMedPubMedCentralCrossRef
287.
Ghanbari M, Iglesias AI, Springelkamp H, van Duijn CM, Ikram MA, Dehghan A, et al. A genome-wide scan for MicroRNA-related genetic variants associated with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2017;58(12):5368–77.PubMedPubMedCentralCrossRef
288.
Mauschitz MM, Bonnemaijer PWM, Diers K, Rauscher FG, Elze T, Engel C, et al. Systemic and ocular determinants of peripapillary retinal nerve fiber layer thickness measurements in the European Eye Epidemiology (E3) population. Ophthalmology. 2018;125(10):1526–36.PubMedCrossRef
289.
Mutlu U, Ikram MK, Roshchupkin GV, Bonnemaijer PWM, Colijn JM, Vingerling JR, et al. Thinner retinal layers are associated with changes in the visual pathway: a population-based study. Hum Brain Mapp. 2018;39(11):4290–301.PubMedCrossRefPubMedCentral
290.
Wen KX, Mutlu U, Ikram MK, Kavousi M, Klaver CC, Tiemeier H, et al. The retinal microcirculation in migraine: the Rotterdam Study. Cephalalgia. 2018;38(4):736–43.PubMedCrossRef
291.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.PubMedCrossRef
292.
Deal JA, Betz J, Yaffe K, Harris T, Purchase-Helzner E, Satterfield S, et al. Hearing impairment and incident dementia and cognitive decline in older adults: the health ABC Study. J Gerontol A Biol Sci Med Sci. 2017;72(5):703–9.PubMed
293.
Smits C, Kapteyn TS, Houtgast T. Development and validation of an automatic speech-in-noise screening test by telephone. Int J Audiol. 2004;43(1):15–28.PubMedCrossRef
294.
Cox RM, Alexander GC. The International Outcome Inventory for Hearing Aids (IOI-HA): psychometric properties of the English version. Int J Audiol. 2002;41(1):30–5.PubMedCrossRef
295.
Newman CW, Sandridge SA, Bolek L. Development and psychometric adequacy of the screening version of the tinnitus handicap inventory. Otol Neurotol. 2008;29(3):276–81.PubMedCrossRef
296.
Homans NC, Metselaar RM, Dingemanse JG, van der Schroeff MP, Brocaar MP, Wieringa MH, et al. Prevalence of age-related hearing loss, including sex differences, in older adults in a large cohort study. Laryngoscope. 2017;127(3):725–30.PubMedCrossRef
297.
Rigters SC, Metselaar M, Wieringa MH, Baatenburg de Jong RJ, Hofman A, Goedegebure A. Contributing determinants to hearing loss in elderly men and women: results from the population-based Rotterdam Study. Audiol Neurootol. 2016;21(Suppl 1):10–5.PubMedCrossRef
298.
Croll PH, Voortman T, Vernooij MW, Baatenburg de Jong RJ, Lin FR, Rivadeneira F, et al. The association between obesity, diet quality and hearing loss in older adults. Aging (Albany NY). 2019;11(1):48–62.PubMedPubMedCentralCrossRef
299.
Rigters SC, Bos D, Metselaar M, Roshchupkin GV, Baatenburg de Jong RJ, Ikram MA, et al. Hearing impairment is associated with smaller brain volume in aging. Front Aging Neurosci. 2017;9:2.PubMedPubMedCentralCrossRef
300.
Rigters SC, Cremers LGM, Ikram MA, van der Schroeff MP, de Groot M, Roshchupkin GV, et al. White-matter microstructure and hearing acuity in older adults: a population-based cross-sectional DTI study. Neurobiol Aging. 2018;61:124–31.PubMedCrossRef
301.
Amin N, de Vrij FMS, Baghdadi M, Brouwer RWW, van Rooij JGJ, Jovanova O, et al. A rare missense variant in RCL1 segregates with depression in extended families. Mol Psychiatry. 2018;23(5):1120–6.PubMedCrossRef
302.
Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668–81.PubMedPubMedCentralCrossRef
303.
Story Jovanova O, Nedeljkovic I, Spieler D, Walker RM, Liu C, Luciano M, et al. DNA methylation signatures of depressive symptoms in middle-aged and elderly persons: meta-analysis of multiethnic epigenome-wide studies. JAMA Psychiatry. 2018;75(9):949–59.PubMedPubMedCentralCrossRef
304.
Saeed Mirza S, Ikram MA, Freak-Poli R, Hofman A, Rizopoulos D, Tiemeier H. 12 year trajectories of depressive symptoms in community-dwelling older adults and the subsequent risk of death over 13 years. J Gerontol A Biol Sci Med Sci. 2018;73(6):820–7.PubMedCrossRef
305.
Schmitz N, Deschenes SS, Burns RJ, Danna SM, Franco OH, Ikram MA, et al. Cardiometabolic dysregulation and cognitive decline: potential role of depressive symptoms. Br J Psychiatry. 2018;212(2):96–102.PubMedCrossRef
306.
Kocevska D, Cremers LGM, Lysen TS, Luik AI, Ikram MA, Vernooij MW, et al. Sleep complaints and cerebral white matter: a prospective bidirectional study. J Psychiatr Res. 2019;112:77–82.PubMedCrossRef
307.
308.
Lysen TS, Wolters FJ, Luik AI, Ikram MK, Tiemeier H, Ikram MA. Subjective sleep quality is not associated with incident dementia: the Rotterdam Study. J Alzheimers Dis. 2018;64(1):239–47.PubMedCrossRef
309.
Lysen TS, Darweesh SKL, Ikram MK, Luik AI, Ikram MA. Sleep and risk of parkinsonism and Parkinson's disease: a population-based study. Brain. 2019;142:2013–22.PubMedPubMedCentralCrossRef
310.
Jones SE, van Hees VT, Mazzotti DR, Marques-Vidal P, Sabia S, van der Spek A, et al. Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour. Nat Commun. 2019;10(1):1585.PubMedPubMedCentralCrossRef
311.
Dashti HS, Jones SE, Wood AR, Lane JM, van Hees VT, Wang H, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10(1):1100.PubMedPubMedCentralCrossRef
312.
Neumann A, Direk N, Crawford AA, Mirza S, Adams H, Bolton J, et al. The low single nucleotide polymorphism heritability of plasma and saliva cortisol levels. Psychoneuroendocrinology. 2017;85:88–95.PubMedCrossRef
313.
Saavedra Perez HC, Direk N, Milic J, Ikram MA, Hofman A, Tiemeier H. The impact of complicated grief on diurnal cortisol levels two years after loss: a population-based study. Psychosom Med. 2017;79(4):426–33.PubMedCrossRef
314.
Milic J, Saavedra Perez H, Zuurbier LA, Boelen PA, Rietjens JA, Hofman A, et al. The longitudinal and cross-sectional associations of grief and complicated grief with sleep quality in older adults. Behav Sleep Med. 2019;17(1):31–40.PubMedCrossRef
315.
Perez HCS, Ikram MA, Direk N, Tiemeier H. Prolonged grief and cognitive decline: a prospective population-based study in middle-aged and older persons. Am J Geriatr Psychiatry. 2018;26(4):451–60.PubMedCrossRef
316.
Chen RQ, Tedroff K, Villamor E, Lu DH, Cnattingius S. Risk of intellectual disability in children born appropriate-for-gestational-age at term or post-term: impact of birth weight for gestational age and gestational age. Eur J Epidemiol. 2020;35(3):273–82.PubMedCrossRef
317.
Lee BK, Gross R, Francis RW, Karlsson H, Schendel DE, Sourander A, et al. Birth seasonality and risk of autism spectrum disorder. Eur J Epidemiol. 2019;34(8):785–92.PubMedPubMedCentralCrossRef
318.
Strohmaier S, Devore EE, Vetter C, Eliassen AH, Rosner B, Okereke OI, et al. Night shift work before and during pregnancy in relation to depression and anxiety in adolescent and young adult offspring. Eur J Epidemiol. 2019;34(7):625–35.PubMedPubMedCentralCrossRef
319.
Modabbernia A, Sandin S, Gross R, Leonard H, Gissler M, Parner ET, et al. Apgar score and risk of autism. Eur J Epidemiol. 2019;34(2):105–14.PubMedCrossRef
320.
321.
Zhong QY, Mittal LP, Nathan MD, Brown KM, Gonzalez DK, Cai TR, et al. Use of natural language processing in electronic medical records to identify pregnant women with suicidal behavior: towards a solution to the complex classification problem. Eur J Epidemiol. 2019;34(2):153–62.PubMedCrossRef
322.
Heuvelman H, Abel K, Wicks S, Gardner R, Johnstone E, Lee B, et al. Gestational age at birth and risk of intellectual disability without a common genetic cause. Eur J Epidemiol. 2018;33(7):667–78.PubMedCrossRef
323.
Marotta PL, McCullagh CA. A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013. Eur J Epidemiol. 2018;33(7):679–88.PubMedCrossRef
324.
Branstrom R, Hatzenbuehler ML, Tinghog P, Pachankis JE. Sexual orientation differences in outpatient psychiatric treatment and antidepressant usage: evidence from a population-based study of siblings. Eur J Epidemiol. 2018;33(6):591–9.PubMedPubMedCentralCrossRef
325.
Agusti A, Faner R, Donaldson G, Heuvelin E, Breyer-Kohansal R, Melén E, et al. Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration. Eur Respir J. 2019;53(3):1900217.PubMedCrossRef
326.
Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45–52.PubMedCrossRef
327.
Artigas MS, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang WB, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet. 2011;43(11):1082–U70.PubMedCentralCrossRef
328.
Loth DW, Artigas MS, Gharib SA, Wain LV, Franceschini N, Koch B, et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014;46(7):669–77.PubMedPubMedCentralCrossRef
329.
Terzikhan N, Sun F, Verhamme FM, Adams HHH, Loth D, Bracke KR, et al. Heritability and genome-wide association study of diffusing capacity of the lung. Eur Respir J. 2018;52(3):1800647.PubMedCrossRef
330.
de Roos EW, Lahousse L, Verhamme KMC, Braunstahl G-J, Ikram MA, in ‘t Veen JCCM, et al. Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study. Respir Med. 2018;139:6–12.
331.
Demenais F, Margaritte-Jeannin P, Barnes KC, Cookson WOC, Altmüller J, Ang W, et al. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet. 2018;50(1):42–53.PubMedCrossRef
332.
Terzikhan N, Lahousse L, Verhamme KMC, Franco OH, Ikram AM, Stricker BH, et al. COPD is associated with an increased risk of peripheral artery disease and mortality. ERJ Open Res. 2018;4(4):00086–2018.PubMedPubMedCentralCrossRef
333.
Lahousse L, Niemeijer MN, van den Berg ME, Rijnbeek PR, Joos GF, Hofman A, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015;36(27):1754–61.PubMedCrossRef
334.
Grymonprez M, Vakaet V, Kavousi M, Stricker BH, Ikram MA, Heeringa J, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118–24.PubMedCrossRef
335.
Hobbs BD, de Jong K, Lamontagne M, Bosse Y, Shrine N, Artigas MS, et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet. 2017;49(3):426–32.PubMedPubMedCentralCrossRef
336.
Nedeljkovic I, Carnero-Montoro E, Lahousse L, van der Plaat DA, de Jong K, Vonk JM, et al. Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics. Eur J Hum Genet. 2018;26(5):709–22.PubMedPubMedCentralCrossRef
337.
Nedeljkovic I, Lahousse L, Carnero-Montoro E, Faiz A, Vonk JM, de Jong K, et al. COPD GWAS variant at 19q13.2 in relation with DNA methylation and gene expression. Hum Mol Genet. 2017;27(2):396–405.PubMedCentralCrossRef
338.
Moreira EM, Gall H, Leening MJG, Lahousse L, Loth DW, Krijthe BP, et al. Prevalence of pulmonary hypertension in the general population: the Rotterdam Study. PLoS ONE. 2015;10(6):e0130072.PubMedPubMedCentralCrossRef
339.
Cepelis A, Brumpton BM, Laugsand LE, Dalen H, Langhammer A, Janszky I, et al. Asthma, asthma control and risk of acute myocardial infarction: HUNT study. Eur J Epidemiol. 2019;34(10):967–77.PubMedCrossRef
340.
Timm S, Frydenberg M, Abramson MJ, Bertelsen RJ, Braback L, Benediktsdottir B, et al. Asthma and selective migration from farming environments in a three-generation cohort study. Eur J Epidemiol. 2019;34(6):601–9.PubMedCrossRef
341.
Weinmayr G, Jaensch A, Ruelius AK, Forastiere F, Strachan DP, Weiland SK, et al. Can environment or allergy explain international variation in prevalence of wheeze in childhood? Eur J Epidemiol. 2019;34(5):509–20.PubMedCrossRef
342.
Campos-Obando N, Lahousse L, Brusselle G, Stricker BH, Hofman A, Franco OH, et al. Serum phosphate levels are related to all-cause, cardiovascular and COPD mortality in men. Eur J Epidemiol. 2018;33(9):859–71.PubMedPubMedCentralCrossRef
343.
Kim Y, White T, Wijndaele K, Westgate K, Sharp SJ, Helge JW, et al. The combination of cardiorespiratory fitness and muscle strength, and mortality risk. Eur J Epidemiol. 2018;33(10):953–64.PubMedPubMedCentralCrossRef
344.
Faerk G, Colak Y, Afzal S, Nordestgaard BG. Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study. Eur J Epidemiol. 2018;33(6):567–77.PubMedCrossRef
345.
Mattila T, Vasankari T, Rissanen H, Knekt P, Puukka P, Heliovaara M. Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period. Eur J Epidemiol. 2018;33(1):89–988.PubMedCrossRef
346.
van Rooij JGJ, Jhamai M, Arp PP, Nouwens SCA, Verkerk M, Hofman A, et al. Population-specific genetic variation in large sequencing data sets: why more data is still better. Eur J Hum Genet. 2017;25(10):1173–5.PubMedPubMedCentralCrossRef
347.
Boomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, Abdellaoui A, et al. The genome of the Netherlands: design, and project goals. Eur J Hum Genet. 2014;22(2):221–7.PubMedCrossRef
348.
Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81(16):6656–67.PubMedCrossRef
349.
Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9.PubMedPubMedCentralCrossRef
350.
van den Akker EB, Pitts SJ, Deelen J, Moed MH, Potluri S, van Rooij J, et al. Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2. Blood. 2016;127(11):1512–5.PubMedPubMedCentralCrossRef
351.
Maas SCE, Vidaki A, Wilson R, Teumer A, Liu F, van Meurs JBJ, et al. Validated inference of smoking habits from blood with a finite DNA methylation marker set. Eur J Epidemiol. 2019;34(11):1055–74PubMedPubMedCentralCrossRef
352.
Liu C, Marioni RE, Hedman AK, Pfeiffer L, Tsai PC, Reynolds LM, et al. A DNA methylation biomarker of alcohol consumption. Mol Psychiatry. 2018;23(2):422–33.PubMedCrossRef
353.
Ligthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255.PubMedPubMedCentralCrossRef
354.
Braun KVE, Dhana K, de Vries PS, Voortman T, van Meurs JBJ, Uitterlinden AG, et al. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study. Clin Epigenetics. 2017;9:15.PubMedPubMedCentralCrossRef
355.
Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541(7635):81–6.PubMedCrossRef
356.
Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, et al. A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease. Diabetes. 2019;68(5):1073–83.PubMedPubMedCentralCrossRef
357.
Nano J, Ghanbari M, Wang W, de Vries PS, Dhana K, Muka T, et al. Epigenome-wide association study identifies methylation sites associated with liver enzymes and hepatic steatosis. Gastroenterology. 2017;153(4):1096–106e2.PubMedCrossRef
358.
Ghanbari M, Peters MJ, de Vries PS, Boer CG, van Rooij JGJ, Lee YC, et al. A systematic analysis highlights multiple long non-coding RNAs associated with cardiometabolic disorders. J Hum Genet. 2018;63(4):431–46.PubMedPubMedCentralCrossRef
359.
Ghanbari M, Munshi ST, Ma B, Lendemeijer B, Bansal S, Adams HH, et al. A functional variant in the miR-142 promoter modulating its expression and conferring risk of Alzheimer disease. Hum Mutat. 2019;40(11):2131–2145.PubMedCrossRef
360.
Ahmad S, Bannister C, van der Lee SJ, Vojinovic D, Adams HHH, Ramirez A, et al. Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study. Alzheimers Dement. 2018;14(7):848–57.PubMedCrossRef
361.
Bjork J, Andersson T, Ahlbom A. Commonly used estimates of the genetic contribution to disease are subject to the same fallacies as bad luck estimates. Eur J Epidemiol. 2019;34(11):987–92.PubMedPubMedCentralCrossRef
362.
363.
Maas SCE, Vidaki A, Wilson R, Teumer A, Liu F, van Meurs JBJ, et al. Validated inference of smoking habits from blood with a finite DNA methylation marker set. Eur J Epidemiol. 2019;34(11):1055–74.PubMedPubMedCentralCrossRef
364.
Mukamal KJ, Stampfer MJ, Rimm EB. Genetic instrumental variable analysis: time to call Mendelian randomization what it is. The example of alcohol and cardiovascular disease. Eur J Epidemiol. 2020;35(2):93–7.PubMedCrossRef
365.
Enthoven CA, LodewijkTideman JW, Polling JR, Tedja MS, Raat H, Iglesias AI, et al. Interaction between lifestyle and genetic susceptibility in myopia: the Generation R study. Eur J Epidemiol. 2019;34(8):777–84.PubMedPubMedCentralCrossRef
366.
Gao X, Gao X, Zhang Y, Holleczek B, Schottker B, Brenner H. Oxidative stress and epigenetic mortality risk score: associations with all-cause mortality among elderly people. Eur J Epidemiol. 2019;34(5):451–62.PubMedCrossRef
367.
Perduca V, Alexandrov LB, Kelly-Irving M, Delpierre C, Omichessan H, Little MP, et al. Stem cell replication, somatic mutations and role of randomness in the development of cancer. Eur J Epidemiol. 2019;34(5):439–45.PubMedCrossRef
368.
Rasmussen IJ, Tybjaerg-Hansen A, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R. Blood-brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals. Eur J Epidemiol. 2019;34(6):579–90.PubMedPubMedCentralCrossRef
369.
Mai XM, Videm V, Sheehan NA, Chen Y, Langhammer A, Sun YQ. Potential causal associations of serum 25-hydroxyvitamin D with lipids: a Mendelian randomization approach of the HUNT study. Eur J Epidemiol. 2019;34(1):57–66.PubMedCrossRef
370.
Burgess S, Labrecque JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol. 2018;33(10):947–52.PubMedPubMedCentralCrossRef
371.
Castagne R, Gares V, Karimi M, Chadeau-Hyam M, Vineis P, Delpierre C, et al. Allostatic load and subsequent all-cause mortality: which biological markers drive the relationship? Findings from a UK birth cohort. Eur J Epidemiol. 2018;33(5):441–58.PubMedPubMedCentralCrossRef
372.
Hang D, Nan HM, Kvaerner AS, De Vivo I, Chan AT, Hu ZB, et al. Longitudinal associations of lifetime adiposity with leukocyte telomere length and mitochondrial DNA copy number. Eur J Epidemiol. 2018;33(5):485–95.PubMedCrossRefPubMedCentral
373.
Liu L, Nevo D, Nishihara R, Cao Y, Song MY, Twombly TS, et al. Utility of inverse probability weighting in molecular pathological epidemiology. Eur J Epidemiol. 2018;33(4):381–92.PubMedCrossRef
374.
Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–81.PubMedCrossRef
375.
Koolhaas CM, van Rooij FJ, Cepeda M, Tiemeier H, Franco OH, Schoufour JD. Physical activity derived from questionnaires and wrist-worn accelerometers: comparability and the role of demographic, lifestyle, and health factors among a population-based sample of older adults. Clin Epidemiol. 2018;10:1–16.PubMedCrossRef
376.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.CrossRefPubMed
377.
Eeftens M, Beelen R, de Hoogh K, Bellander T, Cesaroni G, Cirach M, et al. Development of land use regression models for PM(25), PM(2.5) absorbance, PM(1.0) and PM(coarse) in 20 European study areas; results of the ESCAPE project. Environ Sci Technol. 2012;46(20):11195–205.PubMedCrossRef
378.
Koolhaas CM, van Rooij FJA, Schoufour JD, Cepeda M, Tiemeier H, Brage S, et al. Objective measures of activity in the elderly: distribution and associations with demographic and health factors. J Am Med Dir Assoc. 2017;18(10):838–47.PubMedPubMedCentralCrossRef
379.
Brinkman S, Voortman T, Kiefte-de Jong JC, van Rooij FJA, Ikram MA, Rivadeneira F, et al. The association between lifestyle and overall health, using the frailty index. Arch Gerontol Geriatr. 2018;76:85–91.PubMedCrossRef
380.
Koolhaas CM, Dhana K, Schoufour JD, Lahousse L, van Rooij FJA, Ikram MA, et al. Physical activity and cause-specific mortality: the Rotterdam Study. Int J Epidemiol. 2018;47(5):1705–13.PubMedCrossRef
381.
Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513–23.PubMedPubMedCentralCrossRef
382.
Koolhaas CM, Dhana K, Schoufour JD, Ikram MA, Kavousi M, Franco OH. Impact of physical activity on the association of overweight and obesity with cardiovascular disease: the Rotterdam Study. Eur J Prev Cardiol. 2017;24(9):934–41.PubMedPubMedCentralCrossRef
383.
Koolhaas CM, Dhana K, van Rooij FJA, Schoufour JD, Hofman A, Franco OH. Physical activity types and health-related quality of life among middle-aged and elderly adults: the Rotterdam Study. The journal of nutrition, health & aging. 2018;22(2):246–53.CrossRef
384.
Alferink LJ, Kiefte-de Jong JC, Erler NS, Veldt BJ, Schoufour JD, de Knegt RJ, et al. Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study. Gut. 2019;68(6):1088–98.PubMedCrossRef
385.
de Jonge EAL, Rivadeneira F, Erler NS, Hofman A, Uitterlinden AG, Franco OH, et al. Dietary patterns in an elderly population and their relation with bone mineral density: the Rotterdam Study. Eur J Nutr. 2018;57(1):61–73.PubMedCrossRef
386.
Croll PH, Voortman T, Ikram MA, Franco OH, Schoufour JD, Bos D, et al. Better diet quality relates to larger brain tissue volumes: the Rotterdam Study. Neurology. 2018;90(24):e2166–e73.PubMedCrossRef
387.
de Haas SCM, de Jonge EAL, Voortman T, Graaff JS, Franco OH, Ikram MA, et al. Dietary patterns and changes in frailty status: the Rotterdam study. Eur J Nutr. 2018;57(7):2365–75.PubMedCrossRef
388.
Schoufour JD, Erler NS, Jaspers L, Kiefte-de Jong JC, Voortman T, Ziere G, et al. Design of a frailty index among community living middle-aged and older people: the Rotterdam study. Maturitas. 2017;97:14–20.PubMedCrossRef
389.
Chen Z, Franco OH, Lamballais S, Ikram MA, Schoufour JD, Muka T, et al. Associations of specific dietary protein with longitudinal insulin resistance, prediabetes and type 2 diabetes: the Rotterdam Study. Clin Nutr. 2020;39(1):242–9.PubMedCrossRef
390.
Chen Z, Schoufour JD, Rivadeneira F, Lamballais S, Ikram MA, Franco OH, et al. Plant-based diet and adiposity over time in a middle-aged and elderly population: the Rotterdam Study. Epidemiology (Cambridge, Mass). 2019;30(2):303–10.CrossRef
391.
Stringa N, Brahimaj A, Zaciragic A, Dehghan A, Ikram MA, Hofman A, et al. Relation of antioxidant capacity of diet and markers of oxidative status with C-reactive protein and adipocytokines: a prospective study. Metab Clin Exp. 2017;71:171–81.PubMedCrossRef
392.
Fiorito G, McCrory C, Robinson O, Carmeli C, Rosales CO, Zhang Y, et al. Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis. Aging (Albany NY). 2019;11(7):2045–70.CrossRef
393.
Braun KVE, Dhana K, de Vries PS, Voortman T, van Meurs JBJ, Uitterlinden AG, et al. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study. Clin Epigenet. 2017;9:15.CrossRef
394.
Dhana K, Braun KVE, Nano J, Voortman T, Demerath EW, Guan W, et al. An epigenome-wide association study of obesity-related traits. Am J Epidemiol. 2018;187(8):1662–9.PubMedPubMedCentralCrossRef
395.
Kilpelainen TO, Bentley AR, Noordam R, Sung YJ, Schwander K, Winkler TW, et al. Multi-ancestry study of blood lipid levels identifies four loci interacting with physical activity. Nat Commun. 2019;10(1):376.PubMedPubMedCentralCrossRef
396.
Schoufour JD, de Jonge EAL, Kiefte-de Jong JC, van Lenthe FJ, Hofman A, Nunn SPT, et al. Socio-economic indicators and diet quality in an older population. Maturitas. 2018;107:71–7.PubMedCrossRef
397.
van der Toorn JE, Cepeda M, Kiefte-de Jong JC, Franco OH, Voortman T, Schoufour JD. Seasonal variation of diet quality in a large middle-aged and elderly Dutch population-based cohort. Eur J Nutr. 2020;59(2):493–504.PubMedCrossRef
398.
Cepeda M, Koolhaas CM, van Rooij FJA, Tiemeier H, Guxens M, Franco OH, et al. Seasonality of physical activity, sedentary behavior, and sleep in a middle-aged and elderly population: the Rotterdam study. Maturitas. 2018;110:41–50.PubMedCrossRef
399.
Cepeda M, Muka T, Ikram MA, Franco OH, Schoufour JD. Seasonality of insulin resistance, glucose, and insulin among middle-aged and elderly population: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103(3):946–55.PubMedCrossRef
400.
Merino J, Dashti HS, Li SX, Sarnowski C, Justice AE, Graff M, et al. Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium. Mol Psychiatry. 2019;24(12):1920–32.PubMedCrossRef
401.
Nettleton JA, Follis JL, Ngwa JS, Smith CE, Ahmad S, Tanaka T, et al. Gene x dietary pattern interactions in obesity: analysis of up to 68 317 adults of European ancestry. Hum Mol Genet. 2015;24(16):4728–38.PubMedPubMedCentralCrossRef
402.
Ding M, Huang T, Bergholdt HK, Nordestgaard BG, Ellervik C, Qi L. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study. BMJ. 2017;356:j1000.PubMedPubMedCentralCrossRef
403.
Dashti HS, Zuurbier LA, de Jonge E, Voortman T, Jacques PF, Lamon-Fava S, et al. Actigraphic sleep fragmentation, efficiency and duration associate with dietary intake in the Rotterdam Study. J Sleep Res. 2016;25(4):404–11.PubMedPubMedCentralCrossRef
404.
Abe SK, Saito E, Sawada N, Tsugane S, Ito H, Lin YS, et al. Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan. Eur J Epidemiol. 2019;34(10):917–26.PubMedCrossRef
405.
Mackenbach JP, Valverde JR, Bopp M, Bronnum-Hansen H, Costa G, Deboosere P, et al. Progress against inequalities in mortality: register-based study of 15 European countries between 1990 and 2015. Eur J Epidemiol. 2019;34(12):1131–42.PubMedPubMedCentralCrossRef
406.
Chen GC, Neelakantan N, Martin-Calvo N, Koh WP, Yuan JM, Bonaccio M, et al. Adherence to the Mediterranean diet and risk of stroke and stroke subtypes. Eur J Epidemiol. 2019;34(4):337–49.PubMedCrossRef
407.
Gignac F, Romaguera D, Fernandez-Barres S, Phillipat C, Esteban RG, Lopez-Vicente M, et al. Maternal nut intake in pregnancy and child neuropsychological development up to 8years old: a population-based cohort study in Spain. Eur J Epidemiol. 2019;34(7):661–73.PubMedCrossRef
408.
Giovannucci E. Nutritional epidemiology: forest, trees and leaves. Eur J Epidemiol. 2019;34(4):319–25.PubMedCrossRef
409.
Hashemian M, Farvid MS, Poustchi H, Murphy G, Etemadi A, Hekmatdoost A, et al. The application of six dietary scores to a Middle Eastern population: a comparative analysis of mortality in a prospective study. Eur J Epidemiol. 2019;34(4):371–82.PubMedPubMedCentralCrossRef
410.
Ioannidis JPA. Unreformed nutritional epidemiology: a lamp post in the dark forest. Eur J Epidemiol. 2019;34(4):327–31.PubMedCrossRef
411.
Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019;34(8):731–52.PubMedCrossRef
412.
Li XY, Yu CQ, Guo Y, Bian Z, Shen ZW, Yang L, et al. Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults. Eur J Epidemiol. 2019;34(8):753–63.PubMedPubMedCentralCrossRef
413.
Schwingshackl L, Knuppel S, Michels N, Schwedhelm C, Hoffmann G, Igbal K, et al. Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries. Eur J Epidemiol. 2019;34(8):765–75.PubMedPubMedCentralCrossRef
414.
Temple NJ, Conklin A. Prevalence of overweight and obesity in Western countries: discrepancies in published estimates. Eur J Epidemiol. 2019;34(7):711–3.PubMedCrossRef
415.
van den Brandt PA. Red meat, processed meat, and other dietary protein sources and risk of overall and cause-specific mortality in The Netherlands Cohort Study. Eur J Epidemiol. 2019;34(4):351–69.PubMedPubMedCentralCrossRef
416.
Verhoog S, Marques-Vidal P, Franco OH. Nutritional epidemiology, extinction or evolution? It is all about balance and moderation. Eur J Epidemiol. 2019;34(4):333–5.PubMedCrossRef
417.
Dale MTG, Magnus P, Leirgul E, Holmstrom H, Gjessing HK, Brodwall K, et al. Intake of sucrose-sweetened soft beverages during pregnancy and risk of congenital heart defects (CHD) in offspring: a Norwegian pregnancy cohort study. Eur J Epidemiol. 2019;34(4):383–96.PubMedCrossRef
418.
Jorgensen MB, Pedersen J, Thygesen LC, Lau CJ, Christensen AI, Becker U, et al. Alcohol consumption and labour market participation: a prospective cohort study of transitions between work, unemployment, sickness absence, and social benefits. Eur J Epidemiol. 2019;34(4):397–407.PubMedPubMedCentralCrossRef
419.
Antero-Jacquemin J, Pohar-Perme M, Rey G, Toussaint JF, Latouche A. The heart of the matter: years-saved from cardiovascular and cancer deaths in an elite athlete cohort with over a century of follow-up. Eur J Epidemiol. 2018;33(6):531–43.PubMedCrossRef
420.
Colpani V, Baena CP, Jaspers L, van Dijk GM, Farajzadegan Z, Dhana K, et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):831–45.PubMedCrossRef
421.
Galbete C, Schwingshackl L, Schwedhelm C, Boeing H, Schulze MB. Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses. Eur J Epidemiol. 2018;33(10):909–31.PubMedPubMedCentralCrossRef
422.
Kim R, Kawachi I, Coull BA, Subramanian SV. Patterning of individual heterogeneity in body mass index: evidence from 57 low- and middle-income countries. Eur J Epidemiol. 2018;33(8):741–50.PubMedCrossRef
423.
Patterson R, McNamara E, Tainio M, de Sa TH, Smith AD, Sharp SJ, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur J Epidemiol. 2018;33(9):811–29.PubMedPubMedCentralCrossRef
424.
Zhu DS, Chung HF, Pandeya N, Dobson AJ, Kuh D, Crawford SL, et al. Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studies. Eur J Epidemiol. 2018;33(8):699–710.PubMedCrossRef
425.
Bergholdt HKM, Nordestgaard BG, Varbo A, Ellervik C. Lactase persistence, milk intake, and mortality in the Danish general population: a Mendelian randomization study. Eur J Epidemiol. 2018;33(2):171–81.PubMedCrossRef
426.
Fretts AM, Mete M, Howard BV, Best LG, Siscovick DS, Eilat-Adar S, et al. Physical activity and telomere length in American Indians: the Strong Heart Study. Eur J Epidemiol. 2018;33(5):497–500.PubMedPubMedCentralCrossRef
427.
Hedstrom AK, Stawiarz L, Klareskog L, Alfredsson L. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study. Eur J Epidemiol. 2018;33(4):415–23.PubMedPubMedCentralCrossRef
428.
Lukic M, Nilsson LM, Skeie G, Lindahl B, Braaten T. Coffee consumption and risk of rare cancers in Scandinavian countries. Eur J Epidemiol. 2018;33(3):287–302.PubMedCrossRef
429.
Mulligan AA, Lentjes MAH, Luben RN, Wareham NJ, Khaw KT. Weight change and 15 year mortality: results from the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) cohort study. Eur J Epidemiol. 2018;33(1):37–533.PubMedCrossRef
430.
Song MY, Giovannucci E. Substitution analysis in nutritional epidemiology: proceed with caution. Eur J Epidemiol. 2018;33(2):137–40.PubMedCrossRef
431.
Treur JL, Rozema AD, Mathijssen JJP, van Oers H, Vink JM. E-cigarette and waterpipe use in two adolescent cohorts: cross-sectional and longitudinal associations with conventional cigarette smoking. Eur J Epidemiol. 2018;33(3):323–34.PubMedCrossRef
432.
van den Brandt PA. Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women. Eur J Epidemiol. 2018;33(2):183–200.PubMedPubMedCentralCrossRef
433.
434.
Floyd JS, Bloch KM, Brody JA, Maroteau C, Siddiqui MK, Gregory R, et al. Pharmacogenomics of statin-related myopathy: meta-analysis of rare variants from whole-exome sequencing. PLoS ONE. 2019;14(6):e0218115.PubMedPubMedCentralCrossRef
435.
Postmus I, Warren HR, Trompet S, Arsenault BJ, Avery CL, Bis JC, et al. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins. J Med Genet. 2016;53(12):835–45.PubMedCrossRef
436.
Ahmadizar F, Ochoa-Rosales C, Glisic M, Franco OH, Muka T, Stricker BH. Associations of statin use with glycaemic traits and incident type 2 diabetes. Br J Clin Pharmacol. 2019;85(5):993–1002.PubMedPubMedCentralCrossRef
437.
Pavlovic J, Greenland P, Deckers JW, Brugts JJ, Kavousi M, Dhana K, et al. Comparison of ACC/AHA and ESC guideline recommendations following trial evidence for statin use in primary prevention of cardiovascular disease: results from the population-based Rotterdam Study. JAMA Cardiol. 2016;1(6):708–13.PubMedCrossRef
438.
Irvin MR, Sitlani CM, Noordam R, Avery CL, Bis JC, Floyd JS, et al. Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry. Pharmacogenomics J. 2019;19(1):97–108.PubMedCrossRef
439.
Mahmoudpour SH, Veluchamy A, Siddiqui MK, Asselbergs FW, Souverein PC, de Keyser CE, et al. Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenet Genomics. 2017;27(3):112–9.PubMedPubMedCentralCrossRef
440.
Seyerle AA, Sitlani CM, Noordam R, Gogarten SM, Li J, Li X, et al. Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. Pharmacogenomics J. 2018;18(2):215–26.PubMedCrossRef
441.
Kieboom BCT, Zietse R, Ikram MA, Hoorn EJ, Stricker BH. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population. Pharmacoepidemiol Drug Saf. 2018;27(11):1166–73.PubMedCrossRef
442.
Ham AC, van Dijk SC, Swart KMA, Enneman AW, van der Zwaluw NL, Brouwer-Brolsma EM, et al. Beta-blocker use and fall risk in older individuals: original results from two studies with meta-analysis. Br J Clin Pharmacol. 2017;83(10):2292–302.PubMedPubMedCentralCrossRef
443.
Ham AC, Ziere G, Broer L, Swart KM, Enneman AW, van Dijk SC, et al. CYP2C9 genotypes modify benzodiazepine-related fall risk: original results from three studies with meta-analysis. J Am Med Dir Assoc. 2017;18(1):88e1–88e15.CrossRef
444.
Dujic T, Zhou K, Yee SW, van Leeuwen N, de Keyser CE, Javorsky M, et al. Variants in pharmacokinetic transporters and glycemic response to metformin: a metgen meta-analysis. Clin Pharmacol Ther. 2017;101(6):763–72.PubMedPubMedCentralCrossRef
445.
Zhou K, Yee SW, Seiser EL, van Leeuwen N, Tavendale R, Bennett AJ, et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat Genet. 2016;48(9):1055–9.PubMedPubMedCentralCrossRef
446.
Floyd JS, Sitlani CM, Avery CL, Noordam R, Li X, Smith AV, et al. Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics J. 2018;18(1):127–35.PubMedCrossRef
447.
Aarts N, Noordam R, Hofman A, Tiemeier H, Stricker BH, Visser LE. Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly. Int J Clin Pharm. 2016;38(5):1311–7.PubMedPubMedCentralCrossRef
448.
Aarts N, Zuurbier LA, Noordam R, Hofman A, Tiemeier H, Stricker BH, et al. Use of selective serotonin reuptake inhibitors and sleep quality: a population-based study. J Clin Sleep Med. 2016;12(7):989–95.PubMedPubMedCentralCrossRef
449.
Ham AC, Aarts N, Noordam R, Rivadeneira F, Ziere G, Zillikens MC, et al. Use of selective serotonin reuptake inhibitors and bone mineral density change: a population-based longitudinal study in middle-aged and elderly individuals. J Clin Psychopharmacol. 2017;37(5):524–30.PubMedCrossRef
450.
Noordam R, Aarts N, Peeters RP, Hofman A, Stricker BH, Visser LE. Selective serotonin reuptake inhibitors decrease pancreatic insulin secretion in older adults and increase the risk of insulin dependence in type 2 diabetes patients. J Clin Psychiatry. 2016;77(9):e1124–e9.PubMedCrossRef
451.
Noordam R, Avery CL, Visser LE, Stricker BH. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models. Pharmacogenomics. 2016;17(9):1029–40.PubMedPubMedCentralCrossRef
452.
Noordam R, Sitlani CM, Avery CL, Stewart JD, Gogarten SM, Wiggins KL, et al. A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. J Med Genet. 2017;54(5):313–23.PubMedCrossRef
453.
Noordam R, van den Berg ME, Niemeijer MN, Aarts N, Hofman A, Tiemeier H, et al. Antidepressants and heart-rate variability in older adults: a population-based study. Psychol Med. 2016;46(6):1239–47.PubMedCrossRef
454.
Akoudad S, Aarts N, Noordam R, Ikram MA, Tiemeier H, Hofman A, et al. Antidepressant use is associated with an increased risk of developing microbleeds. Stroke. 2016;47(1):251–4.PubMedCrossRef
455.
Mulder M, Kiefte-de Jong JC, Goessens WH, de Visser H, Hofman A, Stricker BH, et al. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. J Antimicrob Chemother. 2017;72(1):281–9.PubMedCrossRef
456.
Mulder M, Kiefte-de Jong JC, Goessens WHF, de Visser H, Ikram MA, Verbon A, et al. Diet as a risk factor for antimicrobial resistance in community-acquired urinary tract infections in a middle-aged and elderly population: a case-control study. Clin Microbiol Infect. 2019;25(5):613–9.PubMedCrossRef
457.
Mulder M, Radjabzadeh D, Hassing RJ, Heeringa J, Uitterlinden AG, Kraaij R, et al. The effect of antimicrobial drug use on the composition of the genitourinary microbiota in an elderly population. BMC Microbiol. 2019;19(1):9.PubMedPubMedCentralCrossRef
458.
459.
Yang F, Yuan W, Liang H, Song XX, Yu YF, Gelaye B, et al. Preconceptional paternal antiepileptic drugs use and risk of congenital anomalies in offspring: a nationwide cohort study. Eur J Epidemiol. 2019;34(7):651–60.PubMedCrossRef
460.
Hallas J, Wang SV, Gagne JJ, Schneeweiss S, Pratt N, Pottegard A. Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations. Eur J Epidemiol. 2018;33(6):545–55.PubMedCrossRef
461.
462.
Richardson DB, Keil AP. Challenges to studying population effects of medical treatments. Eur J Epidemiol. 2018;33(4):365–8.PubMedCrossRef
463.
Vinke EJ, Huizinga W, Bergtholdt M, Adams HH, Steketee RME, Papma JM, et al. Normative brain volumetry derived from different reference populations: impact on single-subject diagnostic assessment in dementia. Neurobiol Aging. 2019;84:9–16.PubMedCrossRef
464.
Zonneveld HI, Pruim RH, Bos D, Vrooman HA, Muetzel RL, Hofman A, et al. Patterns of functional connectivity in an aging population: the Rotterdam Study. Neuroimage. 2019;189:432–44.PubMedCrossRef
465.
Huizinga W, Poot DHJ, Vernooij MW, Roshchupkin GV, Bron EE, Ikram MA, et al. A spatio-temporal reference model of the aging brain. Neuroimage. 2018;169:11–22.PubMedCrossRef
466.
de Groot M, Cremers LG, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. White matter degeneration with aging: longitudinal diffusion MR imaging analysis. Radiology. 2016;279(2):532–41.PubMedCrossRef
467.
Cremers LG, de Groot M, Hofman A, Krestin GP, van der Lugt A, Niessen WJ, et al. Altered tract-specific white matter microstructure is related to poorer cognitive performance: the Rotterdam Study. Neurobiol Aging. 2016;39:108–17.PubMedCrossRef
468.
Evans TE, O'Sullivan MJ, de Groot M, Niessen WJ, Hofman A, Krestin GP, et al. White matter microstructure improves stroke risk prediction in the general population. Stroke. 2016;47(11):2756–62.PubMedCrossRef
469.
Sedaghat S, Cremers LG, de Groot M, Hofman A, van der Lugt A, Niessen WJ, et al. Lower microstructural integrity of brain white matter is related to higher mortality. Neurology. 2016;87(9):927–34.PubMedCrossRef
470.
Akoudad S, Portegies ML, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study. Circulation. 2015;132(6):509–16.PubMedCrossRef
471.
Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 2016;73(8):934–43.PubMedPubMedCentralCrossRef
472.
Bos D, Portegies ML, van der Lugt A, Bos MJ, Koudstaal PJ, Hofman A, et al. Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam Study. JAMA Neurol. 2014;71(4):405–11.PubMedCrossRef
473.
474.
Doss M. Radiation dose from cardiac catheterization procedures in young patients may not contribute to increased cancer risk. Eur J Epidemiol. 2018;33(4):425–6.PubMedCrossRef
475.
Harbron RW, Chapple CL, O'Sullivan JJ, Lee C, McHugh K, Higueras M, et al. Cancer incidence among children and young adults who have undergone x-ray guided cardiac catheterization procedures. Eur J Epidemiol. 2018;33(4):393–401.PubMedPubMedCentralCrossRef
476.
Harbron RW, Chapple CL, O'Sullivan JJ, Lee C, McHugh K, Higueras M, et al. Suggestion of reduced cancer risks following cardiac x-ray exposures is unconvincing. Eur J Epidemiol. 2018;33(4):427–8.PubMedPubMedCentralCrossRef
477.
White T, Muetzel RL, El Marroun H, Blanken LME, Jansen P, Bolhuis K, et al. Paediatric population neuroimaging and the Generation R Study: the second wave. Eur J Epidemiol. 2018;33(1):99–125.PubMedCrossRef
Metadata
Title
Objectives, design and main findings until 2020 from the Rotterdam Study
Authors
M. Arfan Ikram
Guy Brusselle
Mohsen Ghanbari
André Goedegebure
M. Kamran Ikram
Maryam Kavousi
Brenda C. T. Kieboom
Caroline C. W. Klaver
Robert J. de Knegt
Annemarie I. Luik
Tamar E. C. Nijsten
Robin P. Peeters
Frank J. A. van Rooij
Bruno H. Stricker
André G. Uitterlinden
Meike W. Vernooij
Trudy Voortman
Publication date
01-05-2020
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 5/2020
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-020-00640-5

Other articles of this Issue 5/2020

European Journal of Epidemiology 5/2020 Go to the issue

COVID-19

Burden and prevalence of prognostic factors for severe COVID-19 in Sweden

META-ANALYSIS

Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies

CARDIOVASCULAR DISEASE

Consumption of cocoa-containing foods and risk of hypertension in French women

ESSAY

Rethinking morbidity compression

META-ANALYSIS

Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies

META-ANALYSIS

Dietary protein intake and all-cause and cause-specific mortality: results from the Rotterdam Study and a meta-analysis of prospective cohort studies